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The United States of America has the highest spending in healthcare; however it 
ranks 37 in the quality of care. In addition, the cost of healthcare is increasing at a rate 
higher than that of the gross domestic product(GDP). This had led to some healthcare 
reforms such as the Patient Protection and Affordable Care Act (ACA) and meaningful use 
of electronic health records (EHR). The advent of “Big Data” era and meaningful use of 
EHR data has led to widespread use of patient data for clinical decision support. However, 
given the complex nature of the data, its volume and velocity,  decision making is 
challenging.  
The objective of this research is to develop methodologies for clinical decision 
support which target the prevention of readmission while reducing adverse events such as 
mortality, cardiac arrest and long stay in critical care units. We address challenges such as 
1) missing data 2) the sequential nature of records in the ICU and 3) integration of 
heterogenous data for analysis. In this thesis, we developed novel strategies to solve these 
issues and contribute to this field of computer aided diagnosis using the three specific aims: 
Specific Aim 1: To improve predictive performance by developing imputation techniques 
for missing data in EHR 
Specific Aim 2: To develop predictive models for temporal EHR data 






1.1. Need for Clinical Decision Support Systems for Electronic Health Records 
 The United States of America (USA) has the highest total spending ($3.1 trillion in 
2013 [2]) and per capita (>$8,000 USD) spending in healthcare[3]; however it ranks 37 in 
the quality of care [4] as measured using some key indices such as accessibility, equity, 
efficiency, care quality and health outcomes (infant mortality, life expectancy etc.)(Figures 
1.1, 1.2). In addition, the cost of healthcare is increasing at a rate higher than that of the 
gross domestic product(GDP) [5]. Therefore it stands to reason that unless the process of 
healthcare is made more efficient, the country may no longer be able to sustain its aging 
population with the level of appropriate healthcare. This had led to some healthcare reforms 
such as the Health Information Technology for Economic and Clinical Health (HITECH) 
act in 2009 [6] and Patient Protection and Affordable Care Act (ACA), commonly called 
Obamacare, initiative in 2010 [7], to promote the “meaningful” use of electronic health 
record systems (EHR) [8]. These initiatives, amongst other things, propose the use of data-
 
Figure 1.1: Average per capita health spending 2014 Figure from WHO Global Health 
Expenditure Database 
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driven methods for improving the quality of healthcare while decreasing the cost incurred. 
As the first few steps towards the “meaningful” use of EHR systems, it became mandatory 
for hospitals and vendors to support electronic archival of health records and support data 
interchange policies and APIs [8, 9]. This has resulted in the rapid growth of healthcare 
data volume, which was 150 Exabytes (150 ×1018 bytes) in 2011 [10]. In order to utilize 
this vast and complex source of data for clinical tasks such as clinical tasks: screening, 
diagnosis, prognosis, and resource management, Big Data analytics and tools are 
necessary.  
1.2. Clinical Decision Support and Big Data Analytics in EHR 
 The concept of Big Data refers to the development of decision support systems 
which are capable of handling large and complex datasets[11] and assist the clinicians in 
their decision making. This process involves the processing of raw data to extract 
meaningful information, which in turn is modeled to obtain actionable knowledge using 
data mining techniques (Figure 1.3). Despite extensive research in the field, there remain 
challenges to the decision-making process. This is mainly due to the complexity of the data 
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sets involved. The complexity of the dataset refers to the “five Vs” of big data including 
variety, velocity, veracity, and value [12, 13]. Variety refers to the heterogeneous nature of 
data in most EHR systems, velocity refers to data acquisition rate, veracity refers to the 
quality of data and measured features, and value is the utility of the decision obtained from 
the data. The challenges posed by these can be referred to in data mining terms as  
1) Data quality control 
2) Irregular Sampling of Temporal Data  
3) Heterogeneous data sources. 
  In this work, we use intensive care unit (ICU) data as a case study to develop and 
evaluate methods to overcome these challenges for clinical decision support.  
1.3. Clinical Decision Support in ICU 
 More than 5 million patients are admitted annually to ICUs in the United States 
[14], with children and adolescents accounting for 18% of the hospital stays [15]. Children 
admitted to the ICUs require extensive medical care with high resource utilization [16] . 
 
 







Within hospitalizations, the ICU is often the site of greatest resource utilization because 
these children require high-level nursing, frequent laboratory monitoring, and multiple 
invasive and non-invasive procedures – all of which come at a great expense and often with 
associated complications [17]. Length-of-stay has been shown to be a high-risk factor of 
long-term adverse effects (e.g. neuro-developmental disorders for young kids) associating 
with a higher cost of healthcare [18]. Most ICU studies have focused on adult populations 
(18 years and older) [19, 20], and have shown that the length of stay has significant 
contribution to increased life-threatening outcomes [21, 22] such as severe infection [23, 
24], cardiac arrest [25], ventilation length [26, 27], one-year mortality [28, 29], 
ICU/hospital readmissions [30], acute kidney injury [21, 29], and hypotension [31-33] etc. 
Any intervention, pharmacologic or procedural, that could abbreviate their length of stay 
in ICU and prevent readmissions would have a significant impact on the child’s quality of 
life and society’s overall resource utilization [34-36]. 
 Research investigating the causes of adverse events in the pediatric populations is 
relatively rare. Although some scores of ICU risk assessment are available for pediatric 
populations (e.g., pediatric index of mortality (PIM1&2) [37], and pediatric risk of 
mortality (PRISM, [38-41])), most of them target population of 2-16 years and they 
represent correlations without accounting for the inherent temporal changes embedded in 
the electronic health record data. Scores such as PRISM and PIMS only handle general 
scenarios without the ability for disease-specific modeling, or assessment of ICU length-
of-stay’s impact on young children’s long-term development. Studies have shown that 
data-driven methodologies outperform expert system based risk scores for predicting 
adverse events including mortality [28]. However, the ability to use these modeling 
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techniques for predicting adverse events in the ICU have been confounded due to 
inconsistencies in the data, the heterogeneity of data and the temporal nature of data. In 
this dissertation, we develop and evaluate our models on both adult and pediatric data. 
1.3.1 Data Quality challenges in ICU data 
 The intensive care unit (ICU) is equipped with a multitude of monitoring and 
therapeutic equipment which generate large amounts of complex multimodal data [42]. 
This diversity and the number of parameters being monitored in an ICU make the resulting 
databases highly susceptible to several quality issues in data such as a) missing data and b) 
erroneous data entry [43-48]. The major reason for this situation is that despite 
comprehensive record-keeping, not all values or parameters are obtained in every case 
because tests or measures are only recorded when the clinical team suspects a clinical 
condition based on observations. Therefore, important events may be unobserved and no 
specific data is guaranteed at any time point. The presence of poor quality data in the 
database adversely affects the downstream processing and predictive modeling. Hence the 
issues of data quality pose significant challenges to decision support systems.  
Errors & Inconsistencies in ICU Data 
 Errors and inconsistencies in clinical data are a challenge which has been widely 
recognized in the community. However, there is no consensus on the handling of these 
errors and inconsistencies [49, 50]. Errors in medical data detected using double entry 
method ranged from 2.6-26% [51]. They are generated due to systematic and human errors. 
Not all of the erroneous data is at random [51]. It is mainly detected by checking for 
impossible units and checking for the clinical limits for the data entry [52]. In some studies, 
erroneous data is checked using data distributions [53]. Inconsistencies such as wrong 
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spelling and typing errors are corrected, but other types of errors do not have a clear 
consensus for handling and may contribute towards poor decisions.  
Missing Data in the ICU 
 Missing data is a significant issue in EHR analysis [54], with major repercussions 
on the validity of results generated from downstream data mining of this data. Conventional 
interpolation and imputation schemes generally perform poorly because there are no 
models for modeling the processes which generate missing data [55]. Current imputation 
models in the ICU either try to fill in missing data or delete records with missing values 
[56]. Filling in of missing values is done by using population averages or the means or 
median of the database [57]. Deletion of records is either list wise or pairwise deletion [58-
60]. Deletion leads to a loss of statistical power and mean filling introduces errors in the 
data, which may not accurately reflect the underlying disease state [61]. More accepted 
technique for handling missing data are based on interpolation and model-based 
approaches such as interpolation, multiple imputation [47, 57, 61-64], expectation 
maximization [65-71], maximum likelihood methods [72-74] and hot–deck imputation [75, 
76]. These models, though superior to conventional approaches and interpolation based 
methods still do not account of the patterns inherent in missing data or the missingness 
mechanisms. In statistics and financial literature, missing data is divided into three groups 
on the basis of missingness mechanism. They are (a) missing completely at random 
(MCAR), (b) missing at random (MAR) and (c) missing not at random (MNAR). Since 
there is a semantic gap in the actual terminology and its context in the ICU, we re-phrase 
these terms as follows: “Neglectable” also known as MCAR, “Recoverable” also known 
as MAR and “Not-Easily-Recoverable (NER)” also known as MNAR (Table 1.1).  
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 Data is classified as “Neglectable” if the probability of missing data does not 
depend either on the missing values or other observed data. “Neglectable” data can occur 
in any clinical variable and is independent of observed data. Missing data is classified as 
“Recoverable” if the probability of missing data depends on the observed values of other 
features in the dataset. Missing data is classified as “NER” if the probability of missing 
data depends on the actual missing values. 
 Most current research in health which do use model-based approaches for handling 
missing data assume that all the missing data in the database is either “Neglectable” or 
“Recoverable” [47, 77].  Often times, these assumptions are not mathematically tested and 
may lead to biased conclusions [47, 63]. Some studies, such as those of Sun et al. [63] 
performed analyses to find out the effect of performing missing data analyses on the end 
results (effectiveness of lymphadenectomy). The methods compared were 1) multiple 
imputations to impute missing values; 2) deletion of cases with missing values; and 3) 
making cases with missing values a subcategory. However, this study also mentions that 
the missing data was more likely in patients who had a high tumor grade. This means that 
the data was likely MNAR and the validity of the assumptions made are questionable. 
 However, most of these analysis methods in the ICU which perform some 
operations on missing data, assume that all data is “Neglectable” or “Recoverable” and 
perform imputations [62]. This leads to bias in the results. Zelnick et al. [47] performed 
Table 1.1: Missing Data Types Data Dictionary 
Definition ICU Context Statistical Literature Abbreviations 
“Neglectable” Missing Completely at 
Random 
MCAR 
“Recoverable” Missing at Random MAR 
“Not Easily 
Recoverable (NER)” 




studies on traumatic brain injury to assess the changes in functional outcomes in TBI over 
long term versus those obtained over the short term. They correlated these features with 
long-term prognosis. Missing data was one of the major challenges encountered by this 
group. The used multiple imputation to impute missing data prior to prognosis prediction. 
However, they assessed the data only for “Neglectable” condition and they did not test the 
data for “NER” prior to imputation. The “Neglectable” analysis performed was also not a 
quantitative analysis. These can actually lead to biased conclusions, given that the paper 
could prove that the populations with higher missing data were distinct from the 
populations whose data was available.   
 Jing Tian et al [57] demonstrated the use of a novel imputation method which uses 
a combination of clustering and multiple imputation methods for imputing missing data in 
aerospace research. Their premise was that data imputed from most similar elements will 
better represent the data than ones which use all the data. They also proposed a Gray 
similarity metric to assign clusters to partial data. However, this approach makes use of 
only the complete data for cluster generation. This may not be optimal for ICU where most 
of the data have at least some fields missing. 
 Sun et al [63] performed analyses to find out the effect of performing missing data 
analyses on the end results, which was the effectiveness of lymphadenectomy in this case. 
The compared different three missing data handling techniques methods prior to estimating 
survival using multivariate cox regression. The methods were 1) multiple imputations to 
impute missing values; 2) deletion of cases with missing values, and 3) making cases with 
missing values a subcategory. Their results suggested that lymphadenectomy had no effects 
on survival. Previous studies which used multiple imputations reported the effect due to 
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effects of data handling. However, this analysis deletes data where the missing value is in 
fields other than tumor grade, these could lead to bias in this analysis. In addition, the study 
mentions that the missing data was more likely in patients who had a high tumor grade. 
This means that the data was likely “NER”. These could have contributed to the changes 
in the multiple imputations.  
 Jenkins et al [77] measured the variability of direct nursing cost for similar patients 
and examined the characteristics of nurses assigned to different patient types. Their results 
showed a high variability in nursing intensity and cost per day amongst the different patient 
groups. In their analysis, however, though they analyzed the patterns of missing data, they 
did not perform significant steps to address the same. They deleted records with missing 
nursing data. This value amounted to approximately 25% of their sample size. This could 
have led to loss of statistical power and biased results 
 In this dissertation, we address this issue by developing novel imputation methods 
of each of the three categories.  
1.3.2 Temporal Data Analytics using ICU Data 
Conventional Data Mining Models with ICU Data 
 Population-based studies have shown that prolonged hospital stay contributes 
significantly to increased life-threatening outcomes, which are strongly associated with 
adverse events such as risks in the ICU environment [21, 22], severe infection [23, 24], 
cardiac arrest [25], prolonged duration of mechanical ventilation [26, 27], ICU/hospital 
readmissions [30], high red cell distribution width [56], acute kidney injury [21, 29], and 
hypotension [31-33]. Amongst these models logistic regression and Cox regression are the 
most common models used in the analysis of EHR data. They are advantageous since they 
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do not make any assumptions about the distribution of the data. Fuchs et al. used logistic 
regression and cox regression models to estimate the effect of age and disease severity on 
short- and long-term survival. Their findings suggested that age is nonlinearly associated 
with mortality and should be treated as an independent factor affecting mortality [78]. Lee 
et al. created regression models for patients suffering from hypotensive episodes with fluid 
levels and the dosage of vasoactive agents as predictor variables and mortality and the 
length of stay as response variables. They found that fluid resuscitation is beneficial for 
reducing hospital length of stay and the use of vasoactive agents increases in-hospital 
mortality [33]. The use of more sophisticated data mining techniques such as artificial 
neural networks, support vector machines, and decision trees, outperformed logistic 
regression based scores such as APACHE III with fewer variables [79]. Wong et al. used 
a back-propagation artificial neural network (ANN) and compared it with APACHE II 
scores and found that the ANN models outperformed the APACHE scores. They used 
intensive care unit data for approximately 8000 patients from 26 ICUs [80]. This study 
used that data which showed maximum deviation from mean values for predicting 
mortality. Nguyen et al. used k-nearest neighbors and decision trees on claims data from 
120,000 people to assess the number of days of hospitalizations. They proved that a 
combination of regression and decision trees performed better than either method used 
separately [81]. This goes to suggest that nonlinear decision boundaries may help predict 
health data in a better manner.  
Temporal Data Mining Models with ICU Data 
 Conventional models though very useful for finding risk factors associated with a 
specific disease, could not be used for predicting the risk of a specific treatment plan for 
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an individual patient and do not incorporate the temporal nature of the clinical data. 
Because there is often a delay between the occurrence of a treatment and its influence on 
the outcomes, it is important to study the temporal relationships between events that can 
provide evidence for clinical decision support. For example, myocardial infarction can be 
predicted based on the temporal changes in ECG, and, similarly, hepatitis can be diagnosed 
using the temporal relationship of viral counts.  
 The temporal models commonly seen in the literature include models such as 
sequence analysis [82-86], association rule mining [85, 87, 88], temporal Cox regression 
[89-91] and clustering [92, 93]. Sequence analysis and association rule mining based 
studies require extensive user input for identifying specific features whose patterns of 
correlation can be studied with respect to the target variable. In addition, they are not 
amenable for discerning relationships and patterns contributing to adverse events, from a 
large number of features. Regression [94] and clustering [95] based studies use information 
within a specific time interval for analysis. These studies do not account for the differing 
length of available data for different patients.  Cox regression also does not account for the 
dependency between the consecutive time points. Graphical methods by Liu et. al. uses 
Gaussian processes (GPs) for time-series analysis [96]. Their assumption is that the data is 
piecewise linear and use only the GP coefficients for classification. Such models make the 
assumptions that ICU data can be approximated using piece-wise GPs. Stiglic et. al. used 
past recordings for a single patient to make predictions about a future time instant using 
LASSO regression [97]. The parameters of these models, are trained for each individual 
patients and do not make use of the information which can be learned from large databases 
consisting of multiple patients. Such models not only require the user to train the model for 
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each patient but also tend to over-fit the data. In addition, these models do not tell the 
clinicians if the patients are improving over time.  To the best of our knowledge, there is 
only one study by Lin et. al. [98] which generates individual survival curves. They use a 
series of logistic regression models to calculate the hazard at each time instant. This 
approach is not only very computationally intensive but also does not account for the 
variation in the duration of ICU data. 
 Graphical sequential models such as Markov models and conditional random fields 
have been used for waveform analysis in EHR data [99-103] and may be adapted for other 
types of EHR data as well. Penny et al. used AR-HMM model to look at state changes in 
sections of EEG, recorded over the primary motor cortex, corresponding to imagined finger 
movements [104]. HMMs are generic probabilistic models whose observations may be of 
arbitrary complexity and may be generated via another, nested, probabilistic model [105].  
These methodologies have a potential in sequential data found in EHR also.  
1.3.3 Data Integration  
 Integration of data can be done at multiple levels a) heterogeneous data integration 
within EHR/ICU systems b) multi-modal data integration (e.g. EHR + genomic data 
integration) 
Heterogeneous Data Integration at Multiple Temporal Scales 
 Clinical EHR data consists of administrative data (billing, insurance, procedures 
performed etc.), ancillary clinical data (vital signs, lab tests, medication etc.) , and clinical 
text (physician notes, text observation) [106]. All these values are collected at different 
stages by a variety of personnel as varying frequencies. As a result, the collected data is 
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multivariate and heterogeneous in nature[107]. The data consists of multiple types of 
events with some numeric values and some categorical values. In addition, the sampling is 
also irregular and at diverse temporal scales [108-110]. The advent of deep learning 
techniques such as auto encoders [111-114], convolutional neural networks [115, 116] and 
restricted Boltzmann machines [117-119] have shown progress towards addressing some 
of these challenges of data heterogeneity. The temporal aspects of the EHR data have been 
addressed using methods such recurrent neural networks [120], conditional restricted 
Boltzmann machines [118, 121] and long-short memory networks (LSTM) [122, 123]. 
These models have been used to predictions of a variety of disease conditions using clinical 
EHR/ICU data. Similarly, such methods have been used for waveform data as well for 
adverse event prediction [124-127]. However, the combination of temporal data from 
multiple temporal scales using such deep-learning methods is still is an open research area. 
In our work, we address this challenge using LSTM networks. 
Multi-Modal Data Integration  
 EHR data analytics mainly focuses on predicting future health-related outcomes by 
leveraging personalized longitudinal data to support clinical decision making. However, 
the current data mining models which use only EHR data can predict outcomes only after 
the symptoms are seen. Big data analytics which combines genomic with EHR has been 
identified as one of the research directions which can be employed to improve the early 
prediction of diseases which have a genetic component [106, 128-130]. The potential for 
combining EHR data with genetic data has been shown by the eMERGE consortium [131]. 
The eMERGE network is a National Human Genome Research Institute (NHGRI)-funded 
consortium. The eMERGE network aims to identify causal genomic mutations (mostly 
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single nucleotide proteins (SNPs)) for phenotypic information (e.g., observable phenotypes 
for genetic disorders, drug responses, childhood obesity, and childhood autism) recorded 
in the EMR system, and then integrate identified genotype-phenotype associations into the 
system [131]. In addition, there is also some data mining efforts to show EHR and genetic 
data integration using techniques such as ontology mining with genotype mapping and 
frequent pattern analysis[132, 133]. However, despite the superior performance of deep-
learning techniques, multi-modal deep learning analysis in healthcare seems to be an open 
research area.  
1.4. Proposed Study and Organization of Dissertation 
 In summary, the major challenges of decision support systems are 1) records with 
missing data 2) the sequential nature data in the EHR and 3) heterogeneous and multimodal 
nature of data. In this dissertation, we aim to develop novel strategies to address these 
issues and contribute to this field of computer aided diagnosis through the development of 
robust models which are capable of analyzing time series data in the electronic health 
records (EHR). More specifically the three aims are as follows (Figure 1.4). 
Specific Aim 1: To improve predictive performance by developing imputation techniques 
for missing data in EHR 
Specific Aim 2: To develop predictive models for temporal EHR data 
Specific Aim 3: Data Integration of EHR data using deep learning based predictive models 
 This dissertation focuses on predicting future health-related outcomes by  utilizing 
longitudinal data, starting from improving the quality and integrity of raw EHR data, 
applying data mining and machine learning techniques with selected features to construct 
predictive models and finally delivering knowledge generated by predictive models to 
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support clinical decision making. Lastly, integrative analytics aims to establish a common 
platform that the highly heterogeneous biomedical data can be linked, modeled, and 
interpreted together. 
 The chapter 2 of this thesis focusses on the development of novel imputation 
techniques for missing data with a focus on the type of missing data. The chapters 3 and 4 
deal with the development of temporal data mining models and the combination of 
temporal data at different time scales. Chapter 5 discusses the development of deep 
learning models for EHR data for integration of heterogeneous temporal data at different 
time scales, and chapter 6 discusses the use of deep learning models for integrating EHR 
and SNP data. 
AIM 1 - Quality Control
Improve prediction by developing imputation 
techniques for missing data in EHR
AIM 2 - Temporal Modelling
To develop predictive models for temporal EHR 
data
AIM 3 –Deep Learning 
Data Integration of EHR data using  deep learning 
based predictive models
 Develop data imputation methods for each 
missing data type
Identify Type of Missing Data Temporal data analysis & visualizations  
Ensemble methods for combining static and 
temporal data
Validation on adult and pediatric datasets
Develop deep learning models for EHR
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DATA IMPUTATION FOR MULTIPLE TYPES OF MISSING DATA 
2.1. Introduction 
 As mentioned above the first objective of this dissertation is to address the issue of 
missing data and develop novel imputation techniques for each type of missing data. The 
databases containing ICU are highly susceptible to quality issues, such as missing 
information and erroneous data entry, which adversely affect the downstream processing 
and predictive modeling. Conventional missing data interpolation and imputation 
techniques perform poorly because there are no standards for modeling the missing data. 
Current models for imputing missing data include multiple imputation [47, 57, 61-64], 
expectation maximization [65-71], and hot – deck imputation [75, 76] techniques. These 
techniques are capable of handling only some types of missing data and hence lead to 
biased results[73] if used on all types of missing data.  
 In our research we categorize missing data into three the different types of missing 
data mentioned in Chapter 1, “Neglectable”, “Recoverable” and “Not-Easily-Recoverable 
(NER)”. Then, we address the issues of imputing “Recoverable” and “NER” data in the 
ICU by extending the clustering based approach of Tien et. al. [57] for “Recoverable” data 
imputation and developing a copula-based “NER” imputation technique. Our novel 
“Recoverable” imputation combines the benefit of both expectation maximization 
(accounts for distribution) and hot deck techniques (fewer effects due to cross user 
inconsistencies [134]). The novel imputation methods were then evaluated using two case 
studies. 1) Adult ICU data, and 2) Pediatric ICU data.  
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2.2. Types of Missing Data 
 Missing data is classified as “Neglectable” if the probability of missing data does 
not depend either on the missing values or other observed data. “Neglectable” data can 
occur in any clinical variable and is independent of observed data. Missing data is classified 
as “Recoverable” if the probability of missing data depends on the observed values of other 
features in the dataset. Missing data is classified as “NER” if the probability of missing 
data depends on the actual missing values. In other words, given dataset X with missing 
data in feature Y = [Yobs, Ymiss], where Y is composed of both observed data Yobs and 
missing data Ymiss, the data is “Neglectable” if Ymiss ⊥ X and Ymiss ⊥ Y. The data is 
“Recoverable” if 𝑌𝑚𝑖𝑠𝑠 ⊥ 𝑌 but  𝑌𝑚𝑖𝑠𝑠 ⊺ 𝑋 and it is “NER” if 𝑌𝑚𝑖𝑠𝑠 ⊺ 𝑌. Then we develop 
novel imputation methods for each type of missing data (Table 2.1).  
2.3. Methods 
2.3.2 Identifying the Type of Missing Data 
 As mentioned above there are three types of missing data (Table 2.1), 
“Neglectable,” “Recoverable” and “NER.” First, we analyzed missing data to find if they 
are “Neglectable”. If not, then we distinguish between “Recoverable” and “NER”. If the 
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data is “Recoverable” then we impute the data under “Recoverable” assumptions, else we 
estimate under “NER” assumptions (Figure. 2.1): 
Test for “Neglectable”.  
 There are two tests commonly used in literature, a series of t-tests [135] and Little’s 
test [136], which test whether the missing data is “Neglectable”.  
 A series of t-tests are performed to determine whether data is “Neglectable”. By 
definition, “Neglectable” data refers to missing data that does not depend either on the 
missing values  or observed data. For each feature, we divide the remaining features into 
two groups. The first group has the data where the test feature contains missing values, and 
the second group contains data where there is no missing value in the test feature. If the 
results of t-test show that the two groups are sampled from the same population, then the 
data is “Neglectable”. Since the test is performed on a single feature at a time, missing data 
in other features was disregarded. We performed the t-tests with respect to each of the ‘f’ 
features with Bonferroni corrections to account for multiple testing at a statistical 
significance of 0.05. However, for a total of ‘f’ features, this required a total of ‘f (f-1)’ 
 
 





comparisons where ‘f’ is the number of features, which can become computationally 
expensive for large datasets with thousands of features.  
 This issue is solved using Little’s test [136], which produces a score called Little’s 
score, used for distinguishing “Neglectable” missing data. Little’s score is obtained by 
comparing the means of the original data with maximum likelihood imputed data. This 
score follows the chi-square distribution if the data is “Neglectable.” [136]. A p value less 
than 0.05 rejects the hypothesis that the missing data is “Neglectable”. This was 
implemented in IBM SPSS. Due to memory constraints, we implemented this by taking 
features in batches to test for “Neglectable”. When a current batch was not “Neglectable” 
we did not perform further analysis on the batch. However, if any combination was 
“Neglectable” we combined it with more feature sets (adjacent set) and tested again. 
 Following the test for “Neglectable”, we then distinguished the “Recoverable” from 
“NER” data, prior to imputation. 
Distinguishing “Not-Easily-Recoverable” from “Recoverable.” 
 Data is classified as “Recoverable” if the missing data depends on the other 
features, and it is classified as “NER” if the missing data depends on the missing values. 
Previous research suggests the use of classification schemes to distinguish “Recoverable” 
data from “NER” data [137, 138]. Cismondi et al. [138] used fuzzy classification schemes 
to distinguish “Recoverable” from “NER” data. They proved that non-imputation of 
“NER” data gives better results and lower bias compared to the imputation of all the values. 
The labels for training and classification was generated for each feature by assuming the 
value of 1 if data was missing and 0 otherwise. Any data that was missing and was labeled 
accurately was considered to be missing (“NER”), and those which were mislabeled were 
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considered to be imputable (“Recoverable”). This procedure was repeated for each of the 
different features. We report the correlation between the values of “Recoverable” and 
“NER” data evaluated using the different classification techniques. Then following this, 
we impute the “Recoverable” data and estimate the “NER” data using our novel methods 
described below.  
2.3.2 Missing Data Imputation 
Imputation of “Recoverable” Data 
 Imputation of data under “Recoverable” assumptions has been performed widely 
in medical literature using expectation maximization, and multiple imputations. However, 
these techniques tend to cause cross user inconsistencies and errors due to parameter 
estimations, which are avoided using a clustering based imputation [134]. Previous studies 
using clustering for imputation use only those records where all the data is available, for 
creating the clusters[57]. This approach is not very feasible in environments with a high 
rate of missing data such the ICU. Hence in our study, we propose an alternating least 
squares PCA based clustering approach before imputation so that the effect of missing data 
on the clustering is reduced. 
Robust Clustering based Imputation  
 First, PCA using alternating least squares algorithm is performed on the data. 
Alternating least square based PCA can account for missing data while filling in the 
missing values for the principal components [139]. The total number of principal 
components were chosen to account for 99.99% (chosen to preserve most of the 
information content) of the variance. Then the top principal components were clustered 
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using k-means and fuzzy-C-means (fcm) clustering. In this study, we chose k-means and 
fcm as representative hard and soft clustering techniques[140].We used Calinski Harabasz, 
Davies-Bouldin and silhouette quality metrics for estimating the optimal cluster number. 
The optimal cluster number for each score was computed using the mean of five repetitions, 
and a voting principle was used to compute the number of clusters used for clustering ICU 
data. This step ensures that robust clustering can be performed even in the presence of 
noisy and missing data. Then the imputation was performed in each of the clusters. We 
limited the number of clusters to range from 2-20 in order to ensure data characteristics are 
captured, while keeping in mind the limitations of data size and computational cost. For 
imputing each of the clusters in this study, we used expectation maximization (Figure. 2.1). 
Estimation of data under “Not-Easily-Recoverable” Assumptions 
 By definition “NER” data depends on the missing data and the patterns of missing 
data. The methods for dealing with this type of data in statistics are selection models, 
pattern mixture models [141] and drawn indicator models [142]. All these models assume 
a multivariate normal distribution for estimating “NER” data. A major issue with such 
models is that in the ICU scenario, the distributions are rarely normal. 
In this analysis, we extend drawn indicator models for ICU EHR data. Drawn indicator 
models, use multivariate normal distributions which account for the “missingness” patterns 
in addition to the relationship between the features to model the missing data (Here, the 
“missingness” pattern is defined as the distribution of missing data where a value of 1 is 
given when a specific data is missing and 0 otherwise). When features are not normally 
distributed, then multivariate normal distributions become unreliable models for 
imputation [143]. We overcome this issue using copula functions. 
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A copula function couples N univariate marginal distributions together to form a joint 
distribution function of N standard uniform random variables. It has been shown to be 
invariant to elliptical distributions, deviations from normality and overcomes the issues of 
normal distributions. Hence, we fit a multivariate copula under “NER” assumptions to 
sample from for estimating the “NER” data. In our study, we use a t-copula which is a 
function of the features and the “missingness” pattern 𝑅, (defined as 0 when a certain data 
is observed and 1 when otherwise). 
A function C : [0, 1] p → [0, 1] is a p-dimensional copula if it satisfies the following 
properties:  
1. For all ui ∈ [0, 1], C(1, . . . , 1, ui , 1, . . . , 1) = ui .  
2. For all u ∈ [0, 1] p (i.e. the dim , C(u1, . . . , ud) = 0 if at least one of the coordinates, ui , 
equals zero. 
3. C is grounded and p-increasing, i.e., the C−measure of every box whose vertices lie in 
[0, 1] p is non-negative. 
 
Each of the u is a the marginal distributions of the random variables. 
Consider p continuous random variables (X1, . . . , Xp) with copula C. The multivariate 
copula C is given by  










−1 is the inverse of the marginal distribution of the marginals, 𝑓(𝑡) denotes the copula 
function (i.e. for a t-copula it’s a student’s t distribution) [144, 145]. 
The standard formulation of a t-copula with two continuous random variables  𝑋1, 𝑋2 is 
defined as follows: 
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𝑪(𝑭𝟏(𝑿𝟏), 𝑭𝟐(𝑿𝟐))  =  ∫ ∫
𝟏
𝟐𝝅(𝟏−𝝆𝟐)













𝒅𝒕         (2.1) 
 
where 𝐶 is the copula, and 𝐹1 and 𝐹2 are marginal distribution functions, ρ and ν are the 
parameters of the copula to be set during training, 𝑥1, 𝑥2 are samples sampled from the 
distributions 𝐹1(𝑋1), 𝐹2(𝑋2), and 𝑡𝑣
−1 is the inverse of the standard univariate student-t-
distribution with 𝑣 degrees of freedom, expectation 0 and variance 
𝑣
𝑣−2
 [145, 146]. 
 The continuous copula distribution can be converted into discrete copula using the 
methods described in the paper [146]. In our formulations, we used MATLAB 
implementation of copulafit to fit the copula and sample from the copula [146]. 
 Hence, each feature with missing data 𝑌𝑖 is then sampled from a distribution given by 
 
𝑌𝑖 ~ 𝐶(𝐹1(𝑋1), 𝐹2(𝑋2),… , 𝐹N(𝑋𝑁), 𝐹N+i(𝑅𝑖))   (2.2) 
 
where 𝑋 = [𝑋1, 𝑋2, … , 𝑋𝑁] is the data with 𝑁 features and 𝑅𝑖 is the missingness pattern for 
feature 𝑌𝑖. The parameters for the copula are maximum likelihood estimates fit using 
observed data and the “missingness” pattern at a p-value of 0.05, 0.10 and 0.15.  
Evaluation of the Imputation Methods using Random Forests 
 We evaluate all the heretofore mentioned methods for non-temporal analysis using 
Random Forests to predict ICU mortality on the three datasets and sepsis on two datasets 
(since the number of sepsis patients for the pediatric data was very small). The new 
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methods for imputations were tested against conventional expectation maximization, mean 
filling and no filling, using Random Forests to predict mortality in the ICU.  Random 
Forests was chosen due to its robustness to missing data. The scores used for evaluation 
were accuracy and Mathews correlation coefficient (MCC) and 3 × 3 nested cross-
validation [147]. MCC was chosen as an evaluation since it’s relatively insensitive to an 
imbalance in the population 
Feature Interpretation 
 For each imputation technique, we  report the best performing features in terms of 
their importance scores [148]. We also report the number of features which contributed to 
90% of the prediction for each of the imputation techniques. The importance scores for 
each feature m from a total of M are computed as follows (Figure. 2.2): 
• For a total of N trees, N samples of the training data is generated. 
• For each tree, the data is divided into in the bag samples (used for tree generation) 
and the our of bag samples (OOB) (used for testing the tree). 
 
Figure 2.2: Feature Interpretation: Calculating Importance Scores 
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• The OOB samples for the feature m are permuted and the increase in error is 
computed as the tree importance score. 
• This value is averaged across all the trees to obtain the raw importance score used 
to rank all the features. 
2.4. Results 
 We demonstrate our results for retrospective data analysis using data from both 
Multi-parameter Intelligent Monitoring in Intensive Care, second version, (MIMIC-II) 
database [149] and 'Medical Information Mart for Intensive Care database (MIMIC-
III)[150] 
2.4.1 Case Study 1a: Adult ICU Database – MIMIC-II 
Data Source – MIMIC-II Database 
 MIMIC-II is a public ICU data repository containing over 40,000 ICU stay records 
(32,331 adult and 8080 neonatal records) [149]. The MIMIC II data for each patient is 
either static (does not change over the entire duration of the patient ICU stay, e.g., patient 
demographics) or temporal (changing in time, e.g., heart rate, blood pressure). From a total 
13,000 features in MIMIC-II database, we ranked the features by the number of available 
records. From the top 2000 features, we picked 87 features with the greatest clinical 
significance (based on clinician input). These included measures of physiological 
parameters (e.g. heart rate, blood pressure), lab results (e.g. WBC, RBC, cholesterol), 
administrative data (e.g. length of stay, ICD-9), comorbidities and other diagnostic 
procedures. On this dataset, we performed two type analysis, temporal and non-temporal. 
Non-Temporal Data Analysis 
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 For non-temporal analysis, we used the temporal data by converting it into values 
averaged over the duration of stay. Then outliers whose values were physiologically 
impossible were removed. If the value is normally distributed, then values that deviated by 
±3 standard deviations from the mean value were also removed. After preprocessing and 
outlier removal, the total missing data in the dataset was 30.05% (mean) with a standard 
deviation of 30.8. We performed our analysis using adult data from the MIMIC II database, 
which consists of 32,331 adult records. In this dataset, there were 2,334 patient records 
with mortality during the ICU stay and 29,997 patient records of successful discharge from 
the ICU. The missing data was 30.6% (mean) and 30.9 (standard deviation) in patients with 
successful discharge from the ICU and 22.47 (mean) and 30.44 (standard deviation) in 
patients with ICU mortality. In this dataset, there were 2,010 patient records with sepsis 
during the ICU stay and 29,947 patient records with no sepsis in the ICU. The missing data 
was 25.82% (mean) and 26.39 (standard deviation) in patients with no sepsis in the ICU 
and 29.58 (mean) and 31.61 (standard deviation) in patients with ICU sepsis. 
Temporal Data Analysis 
 For non-temporal analysis, we used the temporal data by converting it into values 
averaged over the duration of stay and for temporal analysis, the data was binned into with 
sampling intervals of 2, 6 and 12 hours. If the data was missing then no substitutions were 
made until aim1. Then outliers whose values were physiologically impossible were 
removed. If the value is distributed normally, then values which deviated by ±3 standard 
deviations from the mean value were removed. After preprocessing and outlier removal, 
the total missing data in the dataset was about 87% (mean) and standard deviation 21. We 
first distinguish the missing data into sampling related and true missing. A data is called 
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true missing if the sampling interval between any two points is greater than 2 times the 
95th percentile of all sampling interval, else it is sampling related. All sampling related 
missing data is imputed using 6 different techniques (cubic, linear, and piecewise linear, 
expectation maximization, nearest neighbor and spline interpolation) and the true missing 
data is handled as mentioned above. 
Test for “Neglectable” Assumption 
 We performed the t-tests and Little’s test. The results of the t-test from non-
temporal analysis (Figure 2.3) demonstrate that most of the p-values reject the null 
hypothesis which states that the means of the two sample populations are derived from 
same distribution, indicating the data is not “Neglectable.” It is supported by the results of 
the Little’s test which showed that the dataset is not “Neglectable” (batch size =5 in Table 
2.2).  
 
Figure 2.3: t-test results: Green row means that particular feature is 
“Neglectable”. Since Green row means that particular feature is “Neglectable”. 
No color means no missing data in feature or the missing data pattern is same as 
test feature. Since no row is green, data is not “Neglectable” 
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 For temporal analysis, since the records of each time point are not independent, and 
t test assumes independence, we performed the t-test against the means for each patient 
The temporal analysis with 6 different interpolation techniques for imputing sampling 
related missing data, also proved that data is not “Neglectable”. Figure 2.4 shows the results 
Table 2.2: Little’s test results (Batch-Size = 5) 
Feature # Chi Square Degrees Freedom  P Value  
Feat 1-5 6023.27 40 0 
Feat 6-10 2062.79 75 0 
Feat 11-15 1382.4 55 0 
Feat 16-20 2275.72 32 0 
Feat 21-25 1062.145 73 0 
Feat 26-30 1767.2 53 0 
Feat 31-35 409.22 46 0 
Feat 36-40 2802.38 27 0 
Feat 41-45 3020.52 4 0 
Feat 46-50 3376.06 15 0 
Feat 51-55 993.54 5 0 
Feat 56-60 1617.11 11 0 
Feat 61-65 7.134 1 0.007 
Feat 66-87 12.549 3 0.005 
 
 
Figure 2.4: t-test results - Temporal: Green row means that particular feature is 
“Neglectable”. These results suggest data is not “Neglectable” a) Cubic b) Spline c) 
Nearest d) Linear e) Piecewise cubic f) Expectation maximization. 
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of 6 of the interpolation techniques for 6hr. The results for 2hr. and 12hr. intervals were 
also similar. This is supported by the results from the Little’s test also where all groups 
showed that the results were not “Neglectable” (Table 2.3). 
Table 2.3: Little’s test results indicate data is not “Neglectable” 
 




















Feat 1-5 679.98 27 0 1130.78 56 0 1363.07 60 0 1395.91 59 0 1421.33 59 0 1575.81 59 0 
Feat 6-10 419.30 28 0 869.35 75 0 1805.19 75 0 2361.28 75 0 2028.26 75 0 1615.81 75 0 
Feat 11-15 518.14 27 0 787.57 51 0 815.62 54 0 924.42 58 0 1660.13 59 0 317.53 58 0 
Feat 16-20 1329.4 28 0 1167.47 71 0 1759.98 73 0 2061.83 73 0 2014.74 73 0 2335.47 73 0 
Feat 21-25 326.39 28 0 413.56 64 0 217.72 58 0 452.57 61 0 803.47 61 0 371.88 61 0 
Feat 26-30 163.36 28 0 174.91 75 0 417.13 71 0 528.68 75 0 491.58 75 0 1146.98 75 0 
Feat 31-33 1447.29 75 0 24.85 9 0 126.86 9 0 209.89 9 0 206.08 9 0 181.35 9 0 
 
 
Figure 2.5: “NER” data identification: The red bar gives percentage of all missing 
data the green bars give the “NER” data percentage. The features which have no 
missing data do not have any bars. 
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Identifying “NER” Data  
 The classification analysis (Figure 2.5) shows very high levels of the missing data 
to be “NER.”(33.2% of the data and 99% of all missing data) for non-temporal analysis. 
Figure 2.6  shows the results of temporal “NER” identification, it shows that though “NER” 
is lower than non-temporal data, it still constitutes 70% of true missing data. Also the 
results are similar across binning intervals. These results indicate that most conventional 
approaches of imputing all the data using “Recoverable” assumptions or deleting may lead 
to bias. In temporal analysis, the percentages of “NER” were found to be lower due to a 
higher correlation between adjacent time points. However, the high levels of “NER” make 
the prediction and data interpretation challenging. Therefore, we perform estimation of data 
under “NER” assumptions.  
 
Figure 2.6: MNAR Data Identification - Temporal: The red line gives the percentage of 




Evaluation using Random Forests 
Evaluation of the imputation models was performed on the non-temporal data using 
Random Forests to predict ICU mortality and sepsis. The list of all features along with the 
category is found in the Appendix. 
Results for Mortality Prediction 
The models where “NER” data was imputed using copulas outperformed all the 
other  models. The k-means based “Recoverable” models outperformed traditional EM 
models, mean filling and no filling techniques (Figures 2.7, 2.8). The statistical significance 
of these models was tested using Steigler’s Z score [151] for correlated correlations from 
the MCC scores.  
 On comparing the prediction performance of our novel methods for statistical 
significance, we found that all the novel models which impute “NER” outperformed EM 
  
Figure 2.7: Mortality prediction results- MCC (fcm = fuzzy c means, km = 
kmeans, EM = expectation maximization, R = “Recoverable”, NER = “Not-
Easily-Recoverable” imputation). NER models gave best performance. 
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algorithm and mean filling imputation techniques with a statistical significance of p ≤ .01. 
All the proposed novel data handling techniques were shown to be performing better than 
no data imputation with a statistical significance of p ≤ .01. The repetitions of NER 
methods with the different p-value parameters (0.05, 0.10 and 0.15) all gave MCC values 






Figure 2.8: Mortality prediction results - Accuracy (fcm = fuzzy c means, km = kmeans, 
EM = expectation maximization, R = “Recoverable”, NER = “Not-Easily-Recoverable” 
imputation). NER models gave best performance. 
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Table 2.4: Top 10 MIMIC-II mortality features in each of the models with the importance scores and the number of 
features accounting for 90% of the total importance. All the features in the order of importance is given in the 


























































































































































































































































































































































































































































































































These results prove that division of missing data into “Neglectable”, “Recoverable” and 
“NER” and the novel imputation methods give a better performance as compared to 
current strategies of EM, mean filling, and no filling.  
Interestingly, the features that were seen to be most indicative of mortality are very 
similar irrespective of the imputation methods. Top ranking features predicted using our 
model (Table 2.4) such as SAP scores, long length of ICU stay, SpO2, comorbidities and 
SOFA scores have been clinically shown to be correlated with mortality [149, 152-158]. 
The features such as SAPS-I [149], ABP [159], age, heart rate, systolic blood pressure, 
body temperature, Glasgow Coma Scale, mechanical ventilation, PaO2, FiO2, urine output, 
BUN (blood urea nitrogen), blood sodium, potassium, bicarbonates, bilirubin, white blood 
cells, chronic disease (AIDS, metastatic cancer, hematologic malignancy) and type of 
admission (elective surgery, medical, unscheduled surgery)[160] have been shown to be 
associated with mortality from other studies using the MIMIC-II dataset. In addition, 
SAPS-I, SpO2, creatinine have been shown to associated with mortality in sepsis patients 
[157]. 
Results for Sepsis Prediction 
The models where “NER” data was imputed using copulas outperformed all the 
other models except mean filling. The “Recoverable” models outperformed traditional EM 
models, and no filling techniques (Figures 2.9, 2.10). The statistical significance of these 
models was tested using Steigler’s Z score [151] for correlated correlations from the MCC 
scores and the results were not statistically significant at p ≤ .01.  
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These results prove that division of missing data into “Neglectable”, “Recoverable” 
  
 
Figure 2.9: Sepsis prediction results- MCC (fcm = fuzzy c means, km = 
kmeans, EM = expectation maximization, R = “Recoverable”, NER = “Not-
Easily-Recoverable” imputation). Excluding mean filling, NER models gave 
best performance. 
  
Figure 2.10: Sepsis prediction results- Accuracy (fcm = fuzzy c means, km = kmeans, 
EM = expectation maximization, R = “Recoverable”, NER = “Not-Easily-Recoverable” 
imputation). Excluding mean filling, NER models gave best performance. 
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and “NER” and the novel imputation methods give a better performance as compared to 
current strategies of EM, and no filling for sepsis.  
Top ranking features predicted using our model (Table 2.5) such as SOFA scores , 
long length of ICU stay, blood pressure, pulse pressure, heart rate, temperature, respiration 
rate, white blood cell count, pH, blood oxygen saturation and age have been clinically 
shown to be correlated with sepsis [161-164]. The features such as blood pressure, pulse 
pressure, heart rate, temperature, respiration rate, white blood cell count, pH, blood oxygen 
saturation, and age have been clinically shown to be correlated with sepsis from other 
studies using the MIMIC-II dataset [164].  
The best performing models from non-temporal analysis models (NER with 
kmeans and fcm) were used for temporal classification and evaluation of temporal models 
was performed using conditional random fields. The results are detailed in chapter 2 and 







Table 2.5: Top 10 MIMIC-II sepsis features in each of the models with the importance 
scores and the number of features accounting for 90% of the total importance. All the 
features in the order of importance is given in the appendix. The features in bold have 




























































































































































































































































































































































































































2.4.2 Case Study 1b: Adult ICU Database – MIMIC-III 
Data Source – MIMIC-III Database 
 MIMIC-III is a public ICU data repository containing 52,963 adult ICU stay 
records. The MIMIC III data for each patient is either static (does not change over the entire 
duration of the patient ICU stay, e.g., patient demographics) or temporal (changing in time, 
e.g., heart rate, blood pressure). From a total 13,000 features in MIMIC-III database, we 
ranked the features by the number of available records. From the top 2000 features, we 
picked 147 features with the greatest clinical significance (based on clinician input) and 
frequency. These included measures of physiological parameters (e.g. heart rate, blood 
pressure), lab results (e.g. WBC, RBC, cholesterol), administrative data (e.g. length of stay, 
ICD-9), comorbidities and other diagnostic procedures. On this dataset, we performed non-
temporal analysis only. 
Non-Temporal Data Analysis 
 For non-temporal analysis, we used the temporal data by converting it into values 
averaged over the duration of stay. Then outliers whose values were physiologically 
impossible were removed. If the value is normally distributed, then values that deviated by 
±3 standard deviations from the mean value were also removed. After preprocessing and 
outlier removal, the total missing data in the dataset was 18.57% (mean) with a standard 
deviation of 26. In this dataset, there were 4,726 patient records with sepsis during the ICU 
stay and 48,237 patient records with no sepsis in the ICU. The missing data was 17.6% 
(mean) and 25.65 (standard deviation) in patients with no sepsis in the ICU and 18.67 
(mean) and 26.57 (standard deviation) in patients with ICU sepsis. In this dataset, there 
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were 6,531 patient records with mortality during the ICU stay and 46,432 patient records 
with no mortality in the ICU. The missing data was 17.69% (mean) and 24.50 (standard 
deviation) in patients with no mortality in the ICU and 18.70 (mean) and 26.80 (standard 
deviation) in patients with ICU mortality. 
Test for “Neglectable” Assumption 
 We performed the t-tests and Little’s test. The results of the t-test from non-
temporal analysis (Figure 2.11) demonstrate that most of the p-values reject the null 
hypothesis which states that the means of the two sample populations are derived from 
same distribution, indicating the data is not “Neglectable.” It is supported by the results of 
the Little’s test which showed that the dataset is not “Neglectable” (Chi-Square = 
936940.041, DF = 667324, Sig. = .000).  
 
Figure 2.11: t-test results: Green row means that particular feature is 
“Neglectable”. Since Green row means that particular feature is “Neglectable”. 
No color means no missing data in feature or the missing data pattern is same as 
test feature. Since no row is green, data is not “Neglectable” 
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Identifying “NER” Data  
 The classification analysis (Figure 2.12) shows very high levels of the missing data 
to be “NER.”(17% of the data and 95% of all missing data). These results indicate that 
most conventional approaches of imputing all the data using “Recoverable” assumptions 
or deleting may lead to bias. to be lower due to a higher correlation between adjacent time 
points. However, the high levels of “NER” make the prediction and data interpretation 
challenging. Therefore, we perform estimation of data under “NER” assumptions.  
Evaluation using Random Forests 
Evaluation of the imputation models was performed on the non-temporal data using 
Random Forests to predict ICU mortality and sepsis. The list of all features along with the 
category is found in the Appendix. 
Results for Mortality Prediction 
 
Figure 2.12: “NER” data identification: The red bar gives percentage of 
all missing data the green bars give the “NER” data percentage. The 
features which have no missing data do not have any bars. 
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The models where “NER” data was imputed using copulas outperformed all the 
other models except mean filling (Figures 2.13, 2.14). The statistical significance of these  
 
Figure 2.13: Mortality prediction results- MCC (fcm = fuzzy c means, km = 
kmeans, EM = expectation maximization, R = “Recoverable”, NER = “Not-
Easily-Recoverable” imputation). Excluding mean filling, NER models gave 
best performance. 
  
Figure 2.14: Mortality prediction results- MCC (fcm = fuzzy c means, km = kmeans, 
EM = expectation maximization, R = “Recoverable”, NER = “Not-Easily-Recoverable” 




Table 2.6: Top 10 MIMIC-III mortality features in each of the models with the importance scores and the 
number of features accounting for 90% of the total importance. All the features in the order of importance is 
given in the appendix. The features in bold have also been reported by other studies using MIMIC-III to be 
indicative of mortality. 
S














































































































































































































































































































































































































































































































































































models was tested using Steigler’s Z score [151] for correlated correlations from the MCC 
scores.  
 On comparing the prediction performance of our novel methods for statistical 
significance, we found that all the novel models which impute “NER” outperformed EM 
algorithm and no filling imputation techniques with a statistical significance of p ≤ .01. 
These results prove that division of missing data into “Neglectable”, “Recoverable” and 
“NER” and the novel imputation methods give a better performance as compared to current 
strategies of EM, mean filling, and no filling.  
 Top ranking features predicted using our model (Table 2.6) such as SAP scores, 
long length of ICU stay, SpO2, comorbidities and SOFA scores have been clinically shown 
to be correlated with mortality [149, 152-158]. The features such as Glasgow Coma Scale, 
systolic blood pressure, diastolic blood pressure, heart rate, temperature, respiration rate, 
SpO2, urine output, FiO2, blood pH, total bilirubin, creatinine, platelets, white blood cell 
count, serum bicarbonate, sodium, potassium, age, PaO2and comorbidities [165-167] have 
been shown to be associated with mortality from other studies using the MIMIC-III dataset. 
Results for Sepsis Prediction 
The models where “NER” data was imputed using copulas outperformed all the 
other models except mean filling. The “Recoverable” models outperformed traditional EM 
models, and no filling techniques (Figures 2.15, 2.16). The statistical significance of these 
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models was tested using Steigler’s Z score [151] for correlated correlations from the MCC 
scores and the results were not statistically significant at p ≤ .01.  
 
Figure 2.16: Sepsis prediction results- MCC (fcm = fuzzy c means, km = kmeans, EM = 




Figure 2.15: Sepsis prediction results- MCC (fcm = fuzzy c means, km = 




These results prove that division of missing data into “Neglectable”, “Recoverable” 
and “NER” and the novel imputation methods give a better performance as compared to 
current strategies of no filling for sepsis.  
Top ranking features predicted using our model (Table 2.7) such as SOFA scores , 
long length of ICU stay, blood pressure, pulse pressure, heart rate, temperature, respiration 
rate, white blood cell count, pH, blood oxygen saturation and age have been clinically 
shown to be correlated with sepsis [161-164]. The features such as Glasgow Coma Scale, 
heart rate, respiration rate, SpO2, blood pressure, and  temperature have been clinically 
shown to be correlated with sepsis from other studies using the MIMIC-III dataset [168].  





Table 2.7: Top 10 MIMIC-III Sepsis Features in each of the Models with the Importance Scores 
and the Number of Features accounting for 90% of the Total Importance. All the Features in the 
Order of Importance is given in the Appendix. All the features in the order of importance is 
given in the appendix. The features in bold have also been reported by other studies using 

























































































































































































































































































































































































































































































































2.4.3 Case Study 2: Pediatric ICU Database 
Data Source – CHOA 
 Our second case study uses de-identified data from Children’s Healthcare of 
Atlanta containing 5000 patient records spanning an 11 month period. Each ICU stay 
record consists of the patient’s demographic information (e.g., gender and age of 
admission), diagnosis (e.g., ICD-9 codes), birth related events (e.g., birth weight, head 
circumference, gestation weeks), microbiology events (e.g., microbes in blood or serum),. 
chart events (e.g., heart rate), medication intake events, microbiology events (e.g., 
microbes), and clinical records (e.g., heart rate, oxygenation) collected from bedside 
monitors, averaged over each min. A more comprehensive measures and number of records 
available from is shown in Table 2.8.  
Table 2.8 Data Types in CHOA database 
Data Type Examples of Measures 
Demographics 
DOB, Gender, Age, Height, Weight, Ethnicity, Religion, Date of Death, Co 
morbidity with other diseases 
Microbiology Types of microbes, Amount of microbes, dilution 
Lab Data 
No of test performance, abnormalities in tests such as Urea, Albumin, 
Bilirubin, Creatinine, Sodium, Potassium, Calcium 
Clinical Data 
HR, Heart rhythm, BP, NBP, CVP, SaO2, Arterial PH, Arterial PaCO2, 
Arterial PaO2, Arterial CO2, SpO2, Respiratory rate, Tidal volume, 
Respiratory effort, Hematocrit, WBC, RBC, 
Medication 
Data 
Medication & IV administered, Dosage, Duration time, Concentrations & 
Rate of Administration, composition of IV imposed 
 
In this case study, we have data consisting of demographics, microbiology, 
diagnosis codes and medication data from which we extracted 9080 features. The missing 
data in this type is 0.08%, hence we used this only for decision making and not for missing 
data analysis. In addition to this we used lab data with a median sampling interval of 2.05 
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hrs. from which we extracted 2500 features and 1 min averaged vital signs data with a 
sampling interval of 1 min, from we extracted 44 features. The lab data consisted of 
information on the tests conducted (labeled as component name), the source of specimens 
(e.g. blood serum, urine and labeled as source), and the number of abnormalities in tests 
and procedures performed (labelled as Result status). The vital signs data consisted on 1 
min average of the actual values. For the missing data analysis, we treat the lab data and 
vital signs data as 2 independent entities due to the varied temporal resolution.  
Non-Temporal Data Analysis 
 For non-temporal analysis, we use the temporal data by converting it into mean 
values. Then features with greater than 80% missing data are removed. This gave us 1882 
lab features and 44 vital signs features. Then outliers whose values which deviated by ±3 
standard deviations from the mean value were removed.  
Temporal Data Analysis 
 For non-temporal analysis, we chose the binning interval to be larger (4 hours for 
lab data and 5 min for wave data) than the median sampling interval. In addition, this 
dataset had an issue where the tests or values were not recorded for very long time intervals 
(~ days) in the middle. For this we treated the data as multiple time-series for each patient 
and did not interpolate the missing data for such large gaps. As a result, we did not 
encounter sampling related missing data in this dataset. In addition, some of the data for 
patients fell outside the range of the visit, in which circumstance we disregarded that data 
as it was most likely mislabeled.  
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 Using a 2 hr. binned interval for lab data we the total missing data in the lab dataset 
was about 65% (mean) and a standard deviation of 2 and that for the vital signs data was 
10% (mean)  and a standard deviation of 18. Then we handled the missing data as stated 
above. 
Test for “Neglectable” Assumption 
 We performed the t-tests and Little’s test. The results of the t-test (Figure 2.17) and 
Little’s (chi-square value 5261.17, degree of freedom of 1943 with a p-value 0.0) from 
non-temporal analysis of vital signs data demonstrates that the CHOA vital signs data is 
not “Neglectable.” It is supported by the results of the temporal analysis which also proved 
that the vital signs data is not “Neglectable” (Figure 2.17). On Lab data also both non-
temporal (Figure 2.18)  and temporal analysis (Figure 2.19) suggest data is not 
“Neglectable”.  
 
Figure 2.17: t-test results temporal vital signs: Green row means that particular feature 
is “Neglectable”. No color means no missing data in feature or the missing data pattern 




Identifying “NER” Data  
 
Figure 2.19: t-test results temporal lab: Green row means that particular feature is 
“Neglectable”. No color means no missing data in feature or the missing data pattern 
is same as test feature. Since no row is green, data is not “Neglectable”. 
 
Figure 2.18: t-test results non-temporal lab: Green row means that particular feature is 
“Neglectable”. No color means no missing data in feature or the missing data pattern 
is same as test feature. Since no row is green, data is not “Neglectable”. 
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 The classification analysis shows very high levels of the missing data to be “NER.” 
for both vital signs for non-temporal analysis (8% of the data and 95% of all missing data, 
Figure 2.20) and for temporal analysis (9.5% of the data and 97% of all missing data, Figure 
2.21). Similarly, lab data also showed high “NER” for both non-temporal (32% of the data  
 
Figure 2.21: “NER” data identification vital signs non-temporal: The red bar gives 
percentage of all missing data the green bars give the “NER” data percentage. The 
features which have no missing data do not have any bars. 
 
Figure 2.20: “NER” data identification vital signs temporal: The red bar gives 
percentage of all missing data the green bars give the “NER” data percentage. The 
features which have no missing data do not have any bars. 
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and 99% of all missing data, Figure 2.22) and temporal (65% of the data and 99% of all 
missing data, Figure 2.23) 
 
Figure 2.23: “NER” data identification lab temporal: The red bar gives percentage of 
all missing data the green bars give the “NER” data percentage. The features which 
have no missing data do not have any bars. 
 
Figure 2.22: “NER” data identification lab non-temporal: The red bar gives 
percentage of all missing data the green bars give the “NER” data percentage. The 
features which have no missing data do not have any bars. 
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Evaluation using Random Forests 
Imputation models were evaluated using Random Forests to predict ICU mortality 
for both vital signs and Lab data. The k-means based “Recoverable” models for Lab data 
outperformed both no filling and mean filling but the results were not significant at p ≤ 
0.01. The “NER” imputation (kmeans and fcm) were comparable to no-filling and mean 
filling (Figure 2.24a). For the vital signs data, the all the novel models outperformed the 
conventional models (Figure 2.24b).  Both imputations with kmeans clustering ( the “NER” 
and “Recoverable” ) were found to be statistically significant (p ≤ 0.01) when the MCCs 
were compared using Steigler’s Z-score [151].  
The top repeated features (Tables 2.9, 2.10) for lab tests included  the number of 
times of several procedures such as  asoti, bilirubin test, biotin test, and for vital signs, it 
includes features such as respiratory rate, blood pressures, pulse, SpO2, heart rates, 
sustained ventricular tachycardia, and abnormal ventricular rhythms.   
 
a      b 
Figure 2.24: Mortality prediction results - MCC (fcm = fuzzy c means, km = kmeans, 
EM = expectation maximization, R = “Recoverable”, NER = “Not-Easily-
Recoverable” imputation).  Figure a gives the results from using lab tests and the figure 





Table 2.9: Top 10 CHOA- vital signs mortality: Features in each of the models with the 
importance scores and the number of features accounting for 90% of the total importance. 
All the features in the order of importance is given in the Appendix. The vital signs data 
was the actual values of the features such as respiratory rate, heart rate. 
S








































































































































































































































































































































































































































































































Table 2.10: Top 10 CHOA- Lab Mortality: Features in each of the models with the 
importance scores and the number of features accounting for 90% of the total importance. 
The lab data consisted of information on the tests and procedures conducted (labeled as 
component name along with the procedure name or the just the test name), the source of 
specimens (e.g. blood serum, urine and labeled as source), and the number of 
abnormalities in tests and procedures performed (labeled as Result status) 
S










































































































































































































































































































































































































































































2.4.4 Results Discussion 
Table 2.11: Top 10 Features for Mortality for Best Performing Models. a. Features from 
MIMIC-II NER; b. Features from MIMIC-III NER; c. Features from CHOA vital signs 





For mortality, we performed the analysis on MIMIC-II, MIMIC-III and CHOA 
datasets. In Table 2.11, we show the features from the best performing models in all the 
three datasets. When we compared the features, we found the common across all the 
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datasets were blood pressure, respiration rate, heart rate, pulse oximetry, albumin, 
creatinine, BUN,WBC and RBC abnormalities. All of these were non-specific ICU 
features. In addition, MIMIC-III and MIMIC-II showed cohort specific features such as 
SAPS and SOFA risk scores. 
For mortality prediction, we also compared features from the MIMIC with that of 
the CHOA data. We found that features such as respiration rate, heart rate, pulse oximetry, 
arterial blood pressure and non-invasive blood pressure were top features in both datasets. 
Features such as height, weight, hematocrit tests, lactic acid, magnesium were on the 
bottom in both. Where features such as RBC, BUN, creatinine were in the middle on 
MIMIC-II features but remained in the top 10% on the CHOA.  Certain comorbidities and 
tests for infection were at the bottom on both datasets. 
For Sepsis, we formed the analysis only on MIMIC-II and MIMIC-III datasets, due 
to small number of sepsis patients in our CHOA dataset. In Table 2.12, we show the 
kmeans NER fcm NER 
Sequential Organ 





Failure Assessment Max 
Hospital Length of 
Stay 
Cost Weight Cost Weight 
Hospital Length of Stay Sequential Organ 
Failure Assessment 
First 
Heart Rate Heart Rate 
NBP ICU Stay Admit Age 
Respiratory Rate Fluid Electrolyte 
Amount 
Total Number of 
Hospital Stays 
Simplified Acute 






Physiology Score I Max 
ICU Stay Length of 
Stay 
a 
kmeans NER fcm NER 
Sequential Organ Failure 
Assessment Cardiovascular 
Sequential Organ Failure 
Assessment Cardiovascular 
Arterial pH Acute Physiology Score III 
Discharge Location Discharge Location 
Age Potassium (3.5-5.3) 
Carbon Dioxide Arterial pH 
Respiratory Rate Age 
BUN (6-20) 
Sequential Organ Failure 
Assessment 
Organ Dysfunction (Y/N) Lactic Acid 
Acute Physiology Score III Creatinine (0-1.3) 
Acute Physiology Scores 
IIIProb Heart Rate 
b 
Table 2.12: Top 10 Features for Sepsis for Best Performing Models. a. Features from 
MIMIC-II NER; b. Features from MIMIC-III NER;  
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features from the our novel methods in the two MIMIC datasets. When we compared the 
features, we found the common across all the datasets were non-specific ICU features such 
as respiration rate, heart rate, age, creatinine, and BUN  abnormalities. In addition, they 
also showed cohort specific features such as SAPS and SOFA risk scores. 
These results allow us to conclude that there are some cohort specific and general 
ICU features which allow the prediction of the endpoints such as mortality which can be 
generalized across datasets. In order to further test the generalizability of the different 
machine learning algorithms developed, we should use the models trained on the adult data 
and test on the pediatric data and vice-versa. In our current datasets, the number and type 
of data between the MIMIC and CHOA datasets is vastly different (mainly due to the issues 
of HIPPA and data availability). In the future, it will interesting to design a study where 
the same features are  collected across different cohorts and the direct applicability/ 
generalizability of our algorithms is tested. This also high-lights a limitation of our current 




2.4.5 Sensitivity Analysis 
There are multiple parts of the missing data imputation where the design choice 
could have been made differently. The figure 2.25 shows the different designs we used to 
test our models.. We performed all our sensitivity analysis using MIMIC-II dataset. 
Sensitivity of the Batch Size and Feature Order in Little’s Test for “Neglectable”  
In order to check whether batch sizes have an effect on the results, we performed 
Little’s test using batch sizes of 3, 5, 7, and 10. Similarly, we repeated the test on three 




Figure 2.25: The various design choices used for which the sensitivity was tested. 
 
Identify True Missing Data Type
• Test dataset for “Deletable” data
• Distinguish “Recoverable” and “Not-Easily-
Recoverable” data 
Impute True Missing Data
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•  Impute “Not-Easily Recoverable” data
Evaluate on MIMIC & CHOA
• Predicting mortality 
•  Sensitivity analysis
Preprocessing
• Identify true missing data
• Impute sampling-related un-sampled data
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Effect of Batch Size on the Result of “Neglectable” Test. 
Table 2.13: Little’s test results (Batch-Size = 3) 
Feature # Chi Square Degrees Freedom P Value 
Feat 1-3 3861.52 9 0 
Feat 4-6 640.16 7 0 
Feat 7-9 732.98 9 0 
Feat 10-12 348.08 9 0 
Feat 13-15 270.03 7 0 
Feat 16-18 186.78 9 0 
Feat 19-21 174.67 9 0 
Feat 22-24 1466.96 9 0 
Feat 25-27 366.07 9 0 
Feat 28-30 55.6 7 0 
Feat 31-33 485.05 9 0 
Feat 34-39 3009.26 3 0 
Feat 40-42 542.5 5 0 
Feat 43-45 1902.69 3 0 
Feat 46-48 392.96 3 0 
Feat 47-87 1117.59 10 0 
 
Table 2.14: Little’s test results (Batch-Size = 5) 
Feature # Chi Square Degrees Freedom P Value 
Feat 1-5 6023.27 40 0 
Feat 6-10 2062.79 75 0 
Feat 11-15 1382.4 55 0 
Feat 16-20 2275.72 32 0 
Feat 21-25 1062.145 73 0 
Feat 26-30 1767.2 53 0 
Feat 31-35 409.22 46 0 
Feat 36-40 2802.38 27 0 
Feat 41-45 3020.52 4 0 
Feat 46-50 3376.06 15 0 
Feat 51-55 993.54 5 0 
Feat 56-60 1617.11 11 0 
Feat 61-65 7.134 1 0.007 




To test the effect of varying batch size on the iterative Little’s test mentioned above, 
we tested the method using batch sizes 3, 5, 7 and  10. Results (Tables 2.13 - 2.16) indicate 
that the dataset is not “Neglectable” for all the different batch sizes and the results are 
independent of batch sizes. A possible reason for this is that if Little’s test indicated 
Table 2.17: Little’s test (Random order 2) 
Feature # Chi Square Degrees Freedom P Value 
Feat 1-5 6023.27 40 0 
Feat 6-10 2062.79 75 0 
Feat 11-15 1382.4 55 0 
Feat 16-20 2275.72 32 0 
Feat 21-25 1062.145 73 0 
Feat 26-30 1767.2 53 0 
Feat 31-35 409.22 46 0 
Feat 36-40 2802.38 27 0 
Feat 41-45 3020.52 4 0 
Feat 46-50 3376.06 15 0 
Feat 51-55 993.54 5 0 
Feat 56-60 1617.11 11 0 
Feat 61-65 7.134 1 0.007 
Feat 66-87 12.549 3 0.005 
 
Table 2.15: Little’s test results (Batch-Size=7) 
Feature # Chi Square Degrees Freedom P Value 
Feat 1-7 7461.42 125 0 
Feat 8-14 7228.7 212 0 
Feat 15-21 2149.5 356 0 
Feat 22-28 2340.69 143 0 
Feat 29-35 903.67 62 0 
Feat 36-42 3945.14 37 0 
Feat 43-49 4358.51 21 0 
Feat 50-87 43.32 6 0 
 
Table 2.16: Little’s test results (Batch-Size=10) 
Feature # Chi Square Degrees Freedom P Value 
Feat 1-10 12646.82 665 0 
Feat 11-20 6928.14 725 0 
Feat 21-30 3803.14 567 0 
Feat 31-40 8278.82 77 0 




“Neglectable” missing data, we combined multiple batches until all the data was used or 
some combination resulted is not “Neglectable”.  
Effect of Feature Order on the Result of “Neglectable” Test. 
 To test the effect of the feature ordering on the iterative Little’s test mentioned 
above, we tested the method on 3 random ordering of the features in the dataset. Since we 
had concluded that the batch sizes did not affect the results based on the previous results 
we used a batch size of 5 for these tests. The results (Tables 2.17, 2.18) indicate that the 
dataset was not “Neglectable” in all of the orderings. The possible reason for this also is 
that the method is rerun until all data is used or some combination is not “Neglectable”. 
Sensitivity of the Classifier Choice for Distinguishing “NER” from “Recoverable”  
 The labels for training and classification was generated for each feature by 
assuming the value of 1 if data was missing and 0 otherwise. We tested neural networks, 
support vector machines (SVM), decision trees and LASSO L1 regularized logistic 
regression to distinguish “Recoverable” from “Not-Easily-Recoverable” since they all give 
a deterministic value each time. Any data that was missing and was labeled accurately was 
Table 2.18: Little’s test (Random order 3) 
Feature # Chi Square Degrees Freedom  P Value 
Feat 1-35 101.19 3 0 
Feat 36-40 1021.11 4 0 
Feat 41-45 3257.49 8 0 
Feat 46-50 532.79 75 0 
Feat 51-55 528.60 75 0 
Feat 56-60 2333.59 33 0 
Feat 61-65 622.90 72 0 
Feat 66-70 857.13 75 0 
Feat 71-75 890.32 69 0 
Feat 76-80 548.01 8 0 




considered to be missing (“Not-Easily-Recoverable”), and those which were mislabeled 
were considered to be imputable (“Recoverable”). This procedure was repeated for each of 
the different features. We report the correlation between the values of “Recoverable” and 
“NER” data evaluated using the different classification techniques.  
The results from all the methods are very similar and show a correlation of greater 
than 0.9 (Table 2.19).  
The results of classification analysis shows very high levels of the missing data to be “Not-
Easily-Recoverable.”(33.2% of the data and 99% of all missing data). These results 
indicate that most conventional approaches of imputing all the data using “Recoverable” 
assumptions or deleting may lead to bias. 
Evaluation of the imputation models was performed using Random Forests to 
predict ICU mortality. The models where “Not-Easily-Recoverable” data was imputed 
using copulas outperformed those where “Not-Easily-Recoverable” data was not imputed. 
The fcm and k-means based “Recoverable” models outperformed traditional EM models 
(Table: 2.20 , 2.21), mean filling and no filling techniques. The MCC and accuracy of the 
novel models were similar irrespective of the classification technique used to distinguish 
the “Recoverable: from “NER” data. The statistical significance of these models was tested 
using Steigler’s Z score [40] for correlated correlations from the MCC scores.  
Table 2.19: Correlation between the “Recoverable” and “NER” data identified by the 
different classification techniques. 
  LASSO Networks Decision Trees SVM 
LASSO 1.00 0.99 0.98 0.98 
Networks 0.99 1.00 0.99 0.99 
Decision Trees 0.98 0.99 1.00 0.98 




Sensitivity of the Parameter Choice for “NER” Imputation  
  For the “NER” imputation we fit a multivariate copula under “NER” assumptions 
to sample from for estimating the “NER” data. In our study, we use a t-copula which is a 
function of the features and the “missingness” pattern R, (defined as 0 when a certain data 
is observed and 1 when otherwise). Each feature with missing data 𝑌𝑖 is then sampled from 
a distribution given by 
𝑌𝑖 ~ 𝐶(𝐹1(𝑋1), 𝐹2(𝑋2), … , 𝐹N(𝑋𝑁), 𝐹N+i(𝑅𝑖)) (2.3) 
 
where 𝑋 = [𝑋1, 𝑋2, … , 𝑋𝑁] is the data with N features and 𝑅𝑖 is the missingness pattern for 
feature pattern for feature 𝑌𝑖. The parameters for the copula are maximum likelihood 
estimates fit using observed data and the “missingness” pattern at a p-value of 0.05. 0.10 
and 0.15.  The copulas with the different p-values all gave MCC values greater than 0.55 
and accuracy greater than 0.95 (Table 2.22). All the MCCs were found to show an 
improvement over conventional techniques with a statistical significance of p ≤ .01. 
Table 2.20: MCC values of classification results of “Recoverable” and “NER” imputation with 
different methods to distinguish “Recoverable from “NER” data. 
Conventional Methods Recoverable Only Recoverable + NER  
No Filling Mean Filling EM kmeans fcm kmeans fcm 
0.35 ± 0.03 0.39 ± 0.04 0.38 ± 0.05 0.4 ± 0.03 0.38 ± 0.03 0.54 ± 
0.03 
0.54 ± 0.01 LASSO 
0.35 ± 0.03 0.39 ± 0.04 0.38 ± 0.05 0.38 ± 0.02 0.37 ± 0.04 0.54 ± 
0.02 
0.54 ± 0.02 Networks 
0.35 ± 0.03 0.39 ± 0.04 0.38 ± 0.05 0.39 ± 0.03 0.36 ± 0.04 0.54 ± 
0.01 
0.54 ± 0.01 Decision 
Trees 0.35 ± 0.03 0.39 ± 0.04 0.38 ± 0.05 0.38 ± 0.05 0.41 ± 0.04 0.54 ± 
0.02 
0.53 ± 0.02 SVM 
 
Table 2.21: Accuracy values of classification results of “Recoverable” and “NER” imputation 
with different methods to distinguish “Recoverable from “NER” data. 
Conventional Methods Recoverable Only Recoverable + NER   
No Filling Mean Filling EM kmeans fcm kmeans Fcm   
0.94 ± 0.003 0.939 ± 0.002 0.94 ± 0.005 0.94 ± 0.002 0.94 ± 0.002 0.95 ± 0.002 0.95 ± 0.001 LASSO 
0.94 ± 0.003 0.939 ± 0.002 0.94 ± 0.005 0.94 ± 0.001 0.94 ± 0.002 0.95 ± 0.002 0.95 ± 0.002 Networks 
0.94 ± 0.003 0.939 ± 0.002 0.94 ± 0.005 0.94 ± 0.002 0.94 ± 0.002 0.95 ± 0.001 0.95 ± 0.001 Decision Trees 




Effect of Population Imbalance on Missing Data Distribution  
 The dataset used in this study contains extremely unbalanced data, 2334 mortality 
records and 29,997 successful discharge records. The missing data was 30.6% ± 30.9% in 
patients with successful discharge from the ICU and 22.47% ± 30.44% in patients with 
ICU mortality. The correlation between the percentages of  NER data in  the two population 
was 0.98 and that of “Recoverable” data in the two populations was 0.87. These results 
indicate that the distribution of missing data in the two populations was similar.  
Table 2.22: MCC and accuracy for NER imputation with different p-Value parameters 
  MCC Accuracy 
P-Value kmeans-NER fcm-NER kmeans-NER fcm-NER 
0.05 0.54  ±  0.03 0.54  ±  0.01 0.95  ±  0.002 0.95  ±  0.001 
0.1 0.56  ±  0.02 0.55  ±  0.02 0.95  ±  0.001 0.95  ±  0.002 
0.15 0.55  ±  0.02 0.55  ±  0.01 0.95  ±  0.002 0.95  ±  0.001 
 
 
Figure 2.26: “Not-Easily-Recoverable” data identification in patients discharged: The red bar 
gives percentage of all missing data the green bars give the “Not-Easily-Recoverable” data 
percentage. The features which have no missing data do not have any bars in this figure. 
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The distribution of the different types of missing in the two populations are given in Figures 
2.26, 2.27. To ensure that despite the imbalance in the populations is accounted when we 
compare the different imputation techniques, we use MCC as the evaluation technique. We 
chose MCC as the evaluation since its relatively insensitive to an imbalance in the 
population.  
 After performing the multiple sensitivity analyses, we conclude and our imputation 
technique is relatively robust to these design choices. 
2.5. Summary and Key Innovations 
 The issues of data quality pose significant challenges to decision support systems. 
Conventional missing data interpolation and imputation schemes perform poorly because 
there are no models for modeling how the data is missing. In this study, we described the  
missing type into three categories namely “Neglectable”, “Recoverable” and “NER”. We 
demonstrated ICU data is not “Neglectable” and any deletion would result in bias. We then 
 
Figure 2.27: “Not-Easily-Recoverable” data identification in patients with ICU mortality: 
The red bar gives percentage of all missing data the green bars give the “Not-Easily-
Recoverable” data percentage. The features which have no missing data do not have any 
bars in this figure. 
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proposed novel imputation for “Recoverable” and “NER” missing data types. We 
evaluated our results on two datasets consisting of adult ICU and pediatric ICU data, where 
our technique gave statistically significant (p ≤ .01) improvement in performance as 
compared with EM, mean filling, and no missing data models. In the future the study 
evaluation can be expanded to use other endpoints such as ICU readmission and sepsis. 
Also for the “Recoverable” data imputation, we used kmeans and fcm for clustering. This 
can be expanded to include more robust of the clustering techniques such as genetic 
algorithms [140], the use of trimming procedures [169], hierarchical and density based 
clustering, in addition to particle swarm optimization [1] and missing interval size [2], 
which directly utilize patient data for clustering.   
 The key innovations of this chapter include: 
• Categorization of and testing of missing data types in ICU 
• Development of two novel methods for two kinds of missing data in EHR 





TIME-SERIES DATA ANALYSIS TO PREDICT ADVERSE 
OUTCOMES IN THE INTENSIVE CARE UNIT 
3.1. Introduction 
 After addressing the challenge of missing data in chapter 1, I used the two best 
performing models (“NER” imputation with kmeans and fcm) for predicting adverse ICU 
outcomes using data temporal analysis. Research on the analysis of patient data to predict 
adverse events such as ICU mortality, ICU readmission and sepsis have mainly used 
probabilistic models. Logistic regression [28, 33, 78], Cox regression [78] and artificial 
neural networks [28, 80, 170] are the most common models used in the analysis of 
healthcare data. However, these models suffer from inherent issues, particularly their basis 
on using a snapshot of the data available to make longitudinal predictions. These models 
often make use of a single time point to make predictions about subsequent adverse events 
occurring in the ICU including mortality and ICU readmission.  
 In this study, we address these issues by proposing a retrospective study of adult 
and pediatric ICU populations to discover factors indicative of adverse events such as ICU 
mortality and 30-day ICU readmissions using Conditional Random Field (CRF) models. 
CRFs are capable of making predictions of time series data by utilizing the parameters 
learned from a large patient population. They are well studied for sequential data such as 
natural language processing [171], structured prediction in computer vision, imaging [172-
174], sleep studies [175, 176] and activity modeling [177-179]. CRFs have also been used 
for waveform analysis in health data [99-103] and are particularly advantageous in the ICU 
over the current models. In this study, we compare CRF with traditional techniques of 
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logistic regression and feed-forward artificial neural networks (NN) for ICU patient data. 
We also extend CRF by combining it with survival analysis to give the physicians an idea 
of the risk to a patient over time.  
 We structure the remainder of this chapter as follows. First, a short description of 
our data source is followed by a detailed description of the preprocessing and data mining 
approaches in section 2. Evaluation, results, and discussion are presented in section 3. 
Finally, the conclusion and key innovations are summarized in section 4. 
3.2. Methods 
In this study, we perform the classification of ICU patients into high risk and low risk 
for adverse events using a temporal mining technique called CRF. We demonstrate our 
results using a retrospective data analysis of adult and neonatal ICU data from Multi-
parameter Intelligent Monitoring in Intensive Care, (MIMIC-II) database. We use CRF to 
determine patient’s factors, which contribute to adverse consequences such as ICU 
mortality, and 30-day ICU readmission. These end-points are particularly interesting since 
they provide the basis for the long-term prediction of adverse events. 
3.2.1 Data Pre-Processing 
 Each ICU stay record consists of the patient’s demographic information, diagnosis, 
chart events, medication intake events, microbiology events etc. Each patient record 
consists of features which are either static (does not change over the entire duration of the 
patient’s ICU stay) or temporal (changing in time). For this analysis, the data from each 
feature was binned using a fixed binning interval. The missing data was divided into the 
three types mentioned in Chapter 1 (“Neglectable”, Recoverable” and “NER”). Then each 
type was imputed differently using the techniques described in Chapter 1 [180]. “NER” 
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data was imputed using student’s t-copulas and “Recoverable” data was imputed using 
expectation maximization (EM) after clustering [180]. Both kmeans (“NER” kmeans) and 
fuzzy C means (“NER” fcm) were used for clustering the data prior to imputation here. We 
will refer to these two imputation techniques as ‘Imp-1’ and ‘Imp-2’.  
 We then proceed to perform feature selection and classification on the patient data 
sequences for identifying patients at risk for adverse events such as mortality in the ICU 
and 30-day readmission  
3.2.2 Feature Selection 
 The data often contains features, which may have low correlation with the outcome 
and sets of features may contain redundant information. In order to remove such features, 
we used L1 feature selection to keep the features space sparse. L1 feature selection 
typically penalizes the absolute values of the weights using a L1 regularization parameter. 
This parameter is set using 3×3 nested cross-validation technique [147].  
3.2.3 Classification using Conditional Random Fields (CRF) 
Following feature selection, we perform classification of ICU temporal data using 
CRF. CRFs are graphical models that encode the probability distribution (𝑝(y|x)) of a set 
of outcomes (y) given the features (x) (e.g. probability distribution of the likelihood of 
patients most likely to suffer adverse consequences such as ICU mortality and ICU 
readmission). It was first introduced by Lafferty et. al. [171] as an improvement over 
existing sequence classification methods such as Markov models because CRFs do not 
require assumptions of independence, and do not place any constraints on the distributions 
of the features and outcome variables. In addition, CRF overcomes the labeling bias (i.e. 
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for Markov models weight distribution is biased towards states with fewer successor states 
due to local weight space) by using a global weight space [171, 181, 182]. 
CRF models (Figure 3.1) directly represent the conditional probability of a 
particular label sequence,y ∈ Y given a sequence of observations x = {x1, x2… xT} i.e. 
p(y|x, θ), where θ is the set of parameters, y is the outcome and x is the feature vector. 
Each of the observations is represented by a feature vector of dimensionality  d (xi  ∈  𝑅
𝑑). 
Each hidden variables h = {h1, h2… hT} represent a higher order feature derived from the 
combination of features x. At any given time instance (t) the observations 𝑥𝑡 connect to the 
nodes in the hidden states h𝑡 that take a value from a finite set H. The probability for patient 
𝑘 P(y𝑘, h|𝑥𝑘 , θ) is given by equation. 3.1. 





    (3.1) 
where θ is the set of parameters estimated during training, φ(y𝑘, h, x𝑘; θ) is the clique 
potential function parameterized by θ. A clique is a fully connected sub-graph  and clique 
potentials are exponential functions of y𝑘 and h in the clique [183]. Cliques in a chain CRF 
(used here) consists of an edge between adjacent hidden variables (ht−1 and ht) and the 
edges from those two outcomes to the set of observations x𝑘 and outcomes y𝑘. 
As a result, CRFs represent the conditional probability as (equations 3.2-3.4): 





h     (3.2) 
where, 
Z =  ∑ e(θ.φ(y
𝑘,h,x𝑘;θ))
y,h     (3.3) 
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φ(y𝑘, 𝜃, ℎ, x𝑘; 𝜃) =∑∑𝑓𝑙






 +  ∑ ∑𝑓𝑙






where, 𝐸, 𝐹 are the number of edges and features respectively. And 𝑓𝑙
1, 𝑓𝑙
2 are 
feature transformation functions (analogous to regression here) 
Hence, the log-likelihood function is given by equation 3.5 








h )    (3.5) 
The value is maximized to learn the parameters θ. The inference is done by forward-
backward inference to obtain the outcome probability from the graph. Over-fitting of the 
CRF model is prevented using L1 regularization of weights (the absolute values of weights 
are penalized).  
 
Figure 3.1: Linear-Chain Hidden Conditional Random Field Structure used to Predict Adverse 
Events in the ICU ( 30 day ICU Readmission and ICU Mortality). 
yk
h1 …
ht ht+1 …     hT
x1
 … xt
           xt+1
 …     xT
 
yk =1         Mortality/re-admission
yk =0        No mortality/ no re-admission
Clinical Features
Clinical Outcomes
ht: hidden state at time t represents combination of features
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ϕ(yk,ht| xk,θ): represents clique potential which is proportional to probability of 




3.2.4 Extension of CRF with Survival Analysis 
 The temporal profile of the hazard faced by patients is essential for physician to 
adjust treatment. In this study (Figure 3.2), we extend the work by Lin et. al. [98] to 
combine CRF with survival curves to show the temporal risk profiles per patient. 
As we know, the probability per patient is given by equation 3.6 
 𝑃(y𝑘|x𝑘) =  
1
𝑍(x𝑘)
× ∑ 𝑒𝑥𝑝 (φ(x𝑘, ℎ, y𝑘; 𝜃))ℎ    (3.6) 
which can be rewritten as equation 3.7 











+ ∑ ∑ 𝑓𝑙
2(𝑗, 𝑘, y𝑘, ℎ𝑗 , ℎ𝑘 , x
𝑘)𝜃𝑙
2
𝑙∈𝐹𝑗,𝑘∈𝐸 } (3.7) 
 
Figure 3.2: Incorporating  Survival Analysis into CRF to Project the Temporal Patient Risk 
Profile by using P(yk,ht|xk,θ) as the Hazard function for Survival Analysis. 
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Example for patient with 4 day stay and 
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readmission with 30 days
 
 74 
The time varying beliefs gives the temporal contribution to the likelihood of the final 
outcome. The time varying beliefs 𝑃(𝑦𝑘, ℎ𝑡|x
𝑘, θ) give the temporal contribution to the 
likelihood of the final outcome at time t. As shown in Fig. 1b, they are equivalent to the 
hazard function in survival analysis to denote the probability of occurrence (or risk) of the 
adverse event at the specific time instant t.  Thus, the survival curve is calculated using the 
equation  3.8 [98] 




)   (3.8) 
In our study we develop a Matlab graphical user interface (GUI) to display these survival 
curves. 
3.2.5 Hyper-Parameter optimization & Evaluation 
 In order to develop an efficient model, the hyper-parameters of the models must be 
estimated to allow for robust performance in a generalizable context. Hence the parameters 
to be optimized in training include the number of hidden variables and L1 regularization 
constant. The estimation of these hyper-parameters and evaluation of the models obtained 
is performed using 3×3 nested cross-validation technique [147]. 
 The data is first split into two (training and validation dataset). The training set is 
further divided into testing and training set in the inner loop. The training-set in the inner 
loop is used to train the model, and the test set is used for parameter optimization. The 
inner loop is used to optimize the two parameters. Three-fold cross validation is performed 
with three repetitions and the average Matthew’s correlation coefficient (MCC) and 
accuracies are computed on the test data. The number of hidden states ranges from 2 to 8, 
and the regularization parameter is varied exponentially from .01 to 100. The best 
performing model is chosen on the basis of best-averaged MCCs. The best performing 
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model is the validated against the validation set (Table 3.1). This whole process is repeated 
3 times to get the average performance of the model. 
 
3.2.6 Comparison of Existing Methods 
 CRF performance was compared with traditional models of logistic regression (LR) 
and feed forward neural networks (NN). LR uses 𝐿1 regularization and Minimum 
Redundancy Maximum Relevance (mRMR) technique [184] to extract features. For L1 
regression, the features with highest coefficients were considered as the selected features. 
NN uses mRMR only for feature ranking because there is no one-to-one correspondence 
of NN weights with the features. In CRF we used L1 regularization only because mRMR 
cannot be done without temporal labels. The number of features obtained from mRMR is 
optimized so that the classification model yields the best average performance on the 
validation set. For traditional methods like LR and NN, they do not take temporal patterns 
automatically. To perform a fair comparison of feature selection between CRF and LR/NN, 
we input an average value of the temporal pattern to LR and NN. 
 The evaluation metrics reported were Matthew’s correlation coefficient (MCC), 
area under the curve (AUC) and accuracies computed on the test data. We also tested the 
CRF models for statistical significance using Steiger’s Z score for correlated correlations 
[151]. 
Table 3.1: Values used for Hyper-parameter Optimization for CRF, LR and NN 
Model Hyperparameter Values 
CRF 
Number of hidden states 2,4,6,8 
Regularization Constant 1,3,10,30,100 
NN 
Number of hidden layers 2,4,6,8 
Number of Features 3,6,9,12,15,18,21,24,27,30 
LR 
Regularization Constant 0.01, 0.03, .1, 0.3, 1,3,10,30 




3.3.  Results & Discussion 
 We demonstrate our methods of patient classification using temporal data (CRF) 
and the use of individual risk profiles using survival curves on adult ICU populations from 
MIMIC-II data. We test our methods on the adult for the end-points ICU mortality and 30 
day ICU readmissions. These end-points represent most common end-points for the 
respective populations in literature and pose great risks to the patients.  
3.3.1 Adult ICU Database – MIMIC-II Database 
 This study is a retrospective data analysis using data from Multi-parameter 
Intelligent Monitoring in Intensive Care, second version, (MIMIC-II) database. MIMIC-II 
is a public ICU data repository containing over 40,000 ICU stay records (32,331 adult and 
8080 neonatal records) [149]. The MIMIC II data for each patient is either static (does not 
change over the entire duration of the patient ICU stay, e.g., patient demographics) or 
temporal (changing in time, e.g., heart rate, blood pressure. A total of 87 features (33 
temporal & 54 static features) which covered clinical measurement, lab results 
administrative data, comorbidities and other diagnostic procedures, were used for 
classification.  The static features defined here are features which do not change during the 
duration of the stay (e.g. presence or absence of cancer, diabetes, age in years, etc.). Hence, 
the static features were repeated at each time instant for the CRF model. 
 After binning into intervals of 6 hours, data had 87± 21% missing data. The missing 
data was imputed as stated above. 
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3.3.2 Results to Predict ICU-Readmission 
A total of 84 features (33 temporal & 51 static features) were used to classify 
patients at risk of 30 day ICU readmission. There are 7,787 patients having an ICU 
readmission within 30 days versus 24,544 without ICU readmission within 30 days.  
The averaged values of MCC, AUC and accuracies is shown in Table 3.2. For each 
of the aforementioned models (CRF, LR, NN), we used two data pre-processing methods 
MNAR with kmeans (Imp-1) and MNAR with fuzzy-c-means (Imp-2).  
Results (Table 3.2) indicate that the CRF Imp-2 (MCC = 0.73±0.03) models 
outperformed all LR and NN models with a statistical significance p ≤ 0.01 when compared 
using Steiger’s Z score for correlated correlations [151]. CRF Imp-1 model outperformed 
all LR models with a statistical significance p ≤ 0.01. Comparing CRF Imp-1 with NN, the 
results were not statistically significant at p ≤ 0.01. This shows that CRF results showed a 
statistically significant improvement at p ≤ 0.01 over LR when using different data 
imputation techniques. 
Table 3.2: Classification Results from ICU Readmission  
(LR = Logistic regression, NN = Neural networks, CRF = Conditional random fields, 














































































We also ran a sensitivity analysis on our models by perturbing the model parameters 
by 10%, one at a time and found that there was no significant changes in the performance. 
Figure 3.3 shows the MCC values when two of most influential weights were perturbed 
using 50 values in the interval ± 10%. This further shows the robustness of the CRF models 
despite noisy data.  
3.3.3 Results to Predict ICU-Mortality 
For the end-point of ICU mortality, all the 87 features (33 temporal & 54 static 
features) were used. There are 2,334 patients who passed away during the ICU stay and 
29,997 patients without mortality in the ICU.  
The averaged values of MCC, AUC and accuracies is shown in Table 3.3. Results 
indicate that the CRF Imp-1 (MCC =0.50 ± 0.033) models outperformed all LR  models 
with a statistical significance p ≤ 0.01. CRF Imp-2 model outperformed L1 regularized LR 
models with a statistical significance p ≤ 0.01. The results of CRF-Imp1 was comparable 
with the NN models 
  
(a)                (b)  
Figure 3.3: 30 day ICU readmission sensitivity plot giving the MCC values when two of most 
influential weights were perturbed using 50 values in the interval ± 10%.  
(a) gives the sensitivity analysis for Imp-1 with MCC  
(b) gives the sensitivity analysis for Imp-1 with MCC  
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We ran a sensitivity analysis on our mortality models by perturbing the model 
parameters by 10%, one at a time and found that there was no significant changes in the 
performance. Figure 3.5 shows the MCC values when two of most influential weights were 
perturbed using 50 values in the interval ± 10%. Similar to the results on ICU- readmission, 
ICU mortality showed a robustness and invariance to perturbations in model parameters.  
So far our results indicate that CRF had better prediction as compared to LR for 
both end-points. It outperformed NN for 30-day ICU readmission and was comparable NN 
  
(b)                (b)  
Figure 3.4: ICU mortality sensitivity plot giving the MCC values when two of most influential 
weights were perturbed using 50 values in the interval ± 10%.  
(a) gives the sensitivity analysis for Imp-1 with MCC  
(b) gives the sensitivity analysis for Imp-1 with MCC  
Table 3.3: Classification Results from ICU Mortality 
(LR = Logistic regression, NN = Neural networks, CRF = Conditional random fields, 






















































































for mortality. In addition, the features picked using temporal models were different from 
those obtained from LR and NN. This leads us to conclude that the addition of temporal 
information gives different patterns in data which could provide more valuable insight into 
the disease processes. In the next aim, we investigate models which can combine the 
advantages and information content captured by both static models (LR, NN) and temporal 
models such as CRF. This type of foresight can help guide both the immediate management 
of a patient and the overall resource utilization.  
3.3.4 Result Interpretation & Discussion 
For each of the two endpoints ICU mortality and 30-day ICU readmission, we 
computed contributions of each of the features towards the final decision. For CRF models, 
the parameters of the models were indicative of the contribution of each feature towards 
the final decision. As mentioned above, we used L1 regularization for feature selection. 
Using the magnitude of parameters generated from the CRF models and L1 regularization, 
we found 90% of the features which contributed to the final decision making and the 
contribution of each of each of the features to the final decision. Similarly, for LR with L1 
regularization, the parameters are the odds ratio and represent the contributions of each 
feature towards the decision (a positive value determines the contribution to the adverse 
event and a negative value determines the contributions to the other class). As with CRF 
used the magnitude of the parameters to determine which features contributed towards 90% 
of the final decision. For the LR and NN where we used mRMR the mutual information 
calculated was used to determine the relative contribution of each feature to the final 
decision making and we used that information to determine the features which contributed 




Results from 30 day ICU-readmission analysis (Figure 3.5, Table 3.4) indicate that 





Figure 3.5: 30 day ICU readmission results showing the top features from CRF 
with L1 regularization- 
 (a) Gives a plot of mutual information with kmeans MNAR imputation i.e. Imp-1 
(b) Gives a plot of mutual information with fcm MNAR imputation i.e. Imp-2 
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absence of disease contributed most to decision. A total of 59 features contributed to 90% 
of the decision. Similarly Imp-2 the Simplified Acute Physiology Score (I) (SAPS-I), 
physiological features and presence or absence of disease contributed most to decision with 
43 features contributing to 90% of the decision. For LR with L1 regularization, for both 
Imp-1 and Imp-2, the top features (Figure 3.6, Table 3.4) which correlated with 
readmission were the hospital length of stay and physiological scores. The top feature 
which correlated with lack of readmission was the presence or absence of blood loss 
anemia. When the absolute value of the parameter values were used for computing the 90% 
contribution, the presence or absence of blood loss anemia contributed towards 90% of the 
distinguishing capacity between the two groups. When only the features which correlated 
with the presence of readmission was considered, a total of 14 for Imp-1 and 16 for Imp-2 
features contributed to 90% of the classification. LR with mRMR  (Figure 3.7, Table 3.4) 
the top features which contributed to classification were the factors such as the total number 
of ICU stays, followed by physiological parameters. For Imp-1, 20 features contributed to 
90% of the classification and for Imp-2, 26 features contributed to 90% of the 
classification. For NN with mRMR (Figure 3.8, Table 3.4) the top features which 
contributed to classification were the number of ICU stays, followed by physiological 
parameters. For Imp-1, 20 features contributed to 90% of the classification and for Imp-2, 







   
(a)        (b)  
 
(c)       (d)  
Figure 3.6: 30 day ICU readmission results showing the top features from LR with L1 
regularization 
(a) Gives a plot with the L1 regularized parameters which are correlated with ICU 
mortality (i.e. parameter value greater than 0 for the kmeans MNAR imputation (Imp1)  
(b) Gives a plot with the L1 regularized parameters which are correlated with no ICU 
mortality (i.e. parameter value less than 0) for the kmeans MNAR imputation (Imp1) 
(c) Gives a plot with the L1 regularized parameters which are correlated with ICU 
mortality (i.e. parameter value greater than 0 for the fcm MNAR imputation (Imp2)  
(d) Gives a plot with the L1 regularized parameters which are correlated with no ICU 




Top ranking features predicted using our model (CRF) such as BUN; creatinine; 
cardiac and pulmonary disorders; ventilation; abnormal vital signs such as hypotension, 






Figure 3.7: 30 day ICU readmission results showing the top features from mRMR with 
LR- 
 (a) Gives a plot of mutual information with kmeans MNAR imputation i.e. Imp-1 
(b) Gives a plot of mutual information with fcm MNAR imputation i.e. Imp-2 
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(WBC) counts; abnormalities in lab results such as potassium, sodium, albumin; 
gastrointestinal and neurological symptoms have been clinically shown to be correlated 
with ICU readmission [185-190]. Outcomes such as sepsis, longer ICU length of stay and 






Figure 3.8: 30 day ICU readmission results showing the top features from mRMR 
with NN- 
 (a) Gives a plot of mutual information with kmeans MNAR imputation i.e. Imp-1 
(b) Gives a plot of mutual information with fcm MNAR imputation i.e. Imp-2 
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Results from mortality analysis (Figure 3.9, Table 3.4) indicate that for CRF with 
L1 regularization, for Imp-1, physiological features and presence or absence of disease 
contributed most to decision. A total of 60 features contributed to 90% of the decision. 
Similarly Imp-2 physiological features and presence or absence of disease contributed most 
to decision with 45 features contributing to 90% of the decision.  
For LR with L1 regression (Figure 3.10, Table 3.4), for both Imp-1 and Imp-2, the 
top features which correlated with mortality were the Simplified Acute Physiology Score 
(I) (SAPS-I) and Sequential Organ Failure Assessment (SOFA) Scores. The top feature 
which correlated with lack of mortality was the presence or absence of blood loss anemia. 
When the absolute value of the parameter values were used for computing the 90% 
contribution, the presence or absence of blood loss anemia contributed towards 90% of the 
distinguishing capacity between the two groups. When only the features which correlated 
with the presence of mortality was considered, a total of 12 features contributed to 90% of 
the classification. LR with mRMR  (Figure 3.11, Table 3.4) the top features which 
contributed to classification were the Simplified Acute Physiology Score (I) (SAPS-I) and 
Sequential Organ Failure Assessment (SOFA) Scores, followed by physiological 
parameters. For Imp-1, 20 features contributed to 90% of the classification and for Imp-2, 
23 features contributed to 90% of the classification. For NN with mRMR (Figure 3.12, 
Table 3.4) the top features which contributed to classification were the Simplified Acute 
Physiology Score (I) (SAPS-I) and Sequential Organ Failure Assessment (SOFA) Scores, 
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Figure 3.9: ICU mortality results showing the top features from CRF with L1 
regularization- 
 (a) Gives a plot of mutual information with kmeans MNAR imputation i.e. Imp-1 
(b) Gives a plot of mutual information with fcm MNAR imputation i.e. Imp-2 
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classification and for Imp-2, 20 features contributed to 90% of the classification.  
   
(a)        (b)  
 
(c)       (d)  
Figure 3.10: ICU mortality results showing the top features from LR with L1 
regularization 
(a) Gives a plot with the L1 regularized parameters which are correlated with ICU 
mortality (i.e. parameter value greater than 0 for the kmeans MNAR imputation (Imp1)  
(b) Gives a plot with the L1 regularized parameters which are correlated with no ICU 
mortality (i.e. parameter value less than 0) for the kmeans MNAR imputation (Imp1) 
(c) Gives a plot with the L1 regularized parameters which are correlated with ICU 
mortality (i.e. parameter value greater than 0 for the fcm MNAR imputation (Imp2)  
(d) Gives a plot with the L1 regularized parameters which are correlated with no ICU 
mortality (i.e. parameter value less than 0) for the fcm MNAR imputation (Imp2) 
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Figure 3.11: ICU mortality results showing the top features from mRMR with LR- 
 (a) Gives a plot of mutual information with kmeans MNAR imputation i.e. Imp-1 









Figure 3.12: ICU mortality results showing the top features from mRMR with 
NN- 
 (a) Gives a plot of mutual information with kmeans MNAR imputation i.e. 
Imp-1 




Top ranking features predicted using our model (CRF) such as SAP scores, long 
length of ICU stay, SpO2, comorbidities and SOFA scores have been clinically shown to 
be correlated with mortality [149, 152-158]. The features such as SAPS-I [149], ABP 
[159], age, heart rate, systolic blood pressure, body temperature, Glasgow Coma Scale, 
Table 3.4:Top 5 features in LR, NN and CRF for all end-points. The list of all features 
with the contribution of each feature to the final decision are given in the appendix. 
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mechanical ventilation, PaO2, FiO2, urine output, BUN (blood urea nitrogen), blood 
sodium, potassium, bicarbonates, bilirubin, white blood cells, chronic disease (AIDS, 
metastatic cancer, hematologic malignancy) and type of admission (elective surgery, 
medical, unscheduled surgery)[160] have been shown to be associated with mortality from 
other studies using the MIMIC-II dataset. In addition, SAPS-I, SpO2, creatinine have been 
shown to be associated with mortality in sepsis patients [157]. 
 
3.3.5 Visualization Results and Extension of CRF with Survival Analysis 
 Once prediction was obtained using CRF models, we developed an interactive 
graphical user interface (GUI), where the temporal risk profile for each patient could be 
viewed for each of the different end-points (Figure 3.6-3.7). The long-term goal for such a 
GUI is to assist physicians in adjusting treatment.  
 
 



















 Interactive GUI was developed for displaying the summary statistics of the 
population as a whole (Figure 3.6). The user can choose the dataset, end point, the 
preprocessing technique and the population of interest. On selecting this, the distribution 
of the age group of the population and the end-point distribution found in the population 
of interest are shown. In addition, the results of the model along with the probability of 
achieving the decision are seen in a graphical and a tabular format. The top features 
identified by the model along with the distribution in the dataset are also displayed. We 
also demonstrate the functionality to show the feature value for each patient along with the 
distributions for normal patients, critical patients with the actual value of the feature 
marked for each patient. We also allow real time input into the models 
 Our GUI (Figure 3.7) has the features to allow the physician plot the risk profiles, 
survival plots and also browse the top features and look at the temporal changes, changes 
in the rate and percentage changes in the different features used. Figure 3.7 shows the 
survival curve for a patient who is at high risk for ICU-mortality. We can see that as the 
 
Figure 3.14: Temporal risk and survival curve. 
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risk increases, there is a corresponding drop in the survival curve, as evidence by the sharp 
downward slope. Such a temporal analysis is highly useful in the clinical setting and has a 
high potential for future clinical decision support.  
 In addition to this we have also developed New user screens (Figure 3.8) are 
developed for using the models to get the prediction for new patients. This screen is 
different for temporal and non-temporal analysis. The non-temporal analysis screen asks 
the values for the top features as selected by the model, displays the value with respect to 
the distributions for that feature and makes a prediction along with the probability. In 
addition, the MCC of the model is given to show the confidence which can be placed on 
this model. 
3.4. Conclusion and Key Innovations 
 Prediction models for end-points such as ICU readmission and mortality remain 
challenging with limited efficacy in a wide variety of patients. State of the art ICU scores 
 
 
Figure 3.15: Single – User Screen – Non-Temporal. 
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do not include ongoing pathologic (acute) processes, processes which can impact long term 
outcomes as well. Our model sought to address this deficiency by looking at the interaction 
of these salient parameters for multiple end-points.  In addition, the temporal nature of 
health records is not widely used for classification in current analytic models. Also, the 
current temporal models are not capable of providing a temporal risk profile for individual 
patients. We address these issues by utilizing a CRF based algorithm to find factors 
indicative of mortality in the ICU, and ICU readmission, using retrospective patient data. 
Our model was evaluated using 3×3 cross validation, where CRF outperformed most LR 
and NN models. It can be easily used to classify new patient data in an additive fashion 
without any retraining, hence proving scalability. As we had mentioned above, CRF 
models pick different features from LR and NN models and could essentially use different 
information to arrive at prediction results.  
 To summarize, the key innovations of this chapter include: 
• Time series data analysis of ICU data without explicit independence assumptions  
• Analysis of adults ICU data for mortality, and readmission 






COMBINATION OF STATIC AND TEMPORAL DATA ANALYSIS 




 The modern intensive care unit (ICU) is a costly component of the national health 
care budgets accounting for 13.7% of hospital costs and 4.1% of national health 
expenditures [191-194]. These costs are largely explained by adverse outcomes such as 
prolonged length of stay in the ICU and ICU readmissions [195, 196]. For these reasons, 
there has been substantial research in developing clinical decision support systems to 
predict and prevent ICU outcomes, including ICU mortality, and ICU readmission.  
 Current research on the use of critical care data has focused on the use of either 
static data (these are generally fixed variables like gender, socioeconomic status, weight 
on admission) , temporal data (such as heart rate, blood pressure, lab tests) or continuous 
data (such as ECG, ECG). Conventional static data analysis using methods such as Cox 
regression and logistic regression though very useful for finding risk factors associated 
with a specific disease, do not incorporate the temporal nature of the clinical data. 
Similarly, temporal models such as sequence analysis and association rule mining [85, 87, 
88] and temporal Cox regression [89-91] generate models using the temporal nature of 
data. However, most of the current work suffer from challenges such as the lack of data 
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analytics that can make sense of patient conditions using a combination of static and 
temporal data (sequential and continuous).  
 In the previous chapter, we performed a temporal analysis using conditional 
random fields (CRF) to predict ICU mortality and 30 day ICU readmissions using adult 
patient data from a publicly available database called MIMIC II [197]. We compared our 
methods using conventional analysis of logistic regression (LR) and neural networks (NN). 
From our analysis we found that more temporal features were selected by CRF models and 
included features such as arterial BP, central venous pressure, creatinine, arterial PaCO2. 
In contrast, the LR and NN models picked features such as max sequential organ failure 
assessment (SOFA) score, metastatic cancer, minimum simplified acute physiology score 
(SAPS) I and presence of neurological symptoms. In addition, the data in the ICU itself is 
collected at higher sampling rates, though this can also vary. 
 In this study we extend our previous work to demonstrate a framework with which 
we can combine data from multiple sources, sampled at different sampling frequencies 
(e.g. static and temporal models (sampled at 6 hour intervals)) using ensemble techniques 
such as hard and soft voting. The static models include logistic regression and feed-forward 
neural networks, and the temporal models include conditional random fields. We combined 
the decisions from these individual classifiers and demonstrate our results using adult data 
from Multi-parameter Intelligent Monitoring in Intensive Care (MIMIC) –II. 
4.2. Methods 
In this work, we perform a retrospective analysis of ICU data for adult patients to 
demonstrate the advantages of the combination of static and temporal data mining. After 
data preprocessing, we perform static data analysis using logistic regression and feed-
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forward neural networks, and temporal data analysis using conditional random fields. We 
then combine the decisions of these different classifiers using hard and soft voting 
techniques (Figure 4.1.). 
4.2.1 Data Preprocessing 
The pre-processing of data for non-temporal analysis was performed by averaging 
the temporal data over the duration of stay. For temporal analysis, we binned the data to 
reduce the effects of missing data. Then outliers whose values were physiologically 
impossible were removed. If the value is normally distributed, then values that deviated by 
±3 standard deviations from the mean value were also removed. The missing data was 
divided into the three types mentioned in Chapter 1 (“Neglectable”, Recoverable” and 
“NER”). Then each type was imputed differently using the techniques described in Chapter 
1 [180]. “NER” data was imputed using student’s t-copulas and “Recoverable” data was 
imputed using expectation maximization (EM) after clustering [180]. Both kmeans 
Data Preprocessing & Imputation
MIMIC-II
(32,331 Adults)






Hard & Weighted Voting




Figure 4.1: Combining static and temporal models. 
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(“NER” kmeans) and fuzzy C means (“NER” fcm) were used for clustering the data prior 
to imputation here. We will refer to these two imputation techniques as ‘Imp-1’ and ‘Imp-
2’. 
4.2.2 Data Mining on Static Data 
For the analysis of static data, we use logistic regression and feed-forward neural 
networks, which are the most commonly used models in healthcare, to predict the patient 
outcomes of the study, ICU mortality and 30 day ICU readmission. A logistic regression 
model is trained for each of the outcomes using a feature set X = {x1, x2… xn} derived 
from the clinical measures mentioned above. Logistic regression model calculates the 




     (4.1) 
The outcome group (y) is assumed to be true (1) when the probability hθ exceeds a 
certain threshold. The values of parameters θ = (θ0, θ1, θ2,… θn) are trained from the 
training data set by maximizing log-likelihood. In order to prevent over fitting we used L2 
regularization and minimum-redundancy maximum-relevancy (mRMR) for feature 
selection [198]. Hence the hyper parameters to be trained include the regularization 
parameter and the number of features. 
Feedforward neural networks (ANN) are essentially mathematical models defining 
a function f ∶ X → Y or a distribution over input (X) or both input (X) and outcome (Y). 
The neural network consists of many interconnected nodes with each input from the input 
layer being fed up to each node in the hidden layer, and from there to each node on the 
output layer. The hyper-parameters of the model include the number of nodes and layers 
when optimizing the neural network. In this study, the number of input layer nodes equaled 
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the number of features from which an optimal number was selected using mRMR and the 
number of hidden layers equaled 1. Hence, the hyper parameters optimized were the 
number of hidden layer units and the number of features selected using mRMR. The 
optimization of the hyper parameters for both these techniques were performed using 3×3 
nested cross-validation. 
4.2.3 Data Mining on Temporal Data 
For the analysis of temporal patient data we used conditional random fields (CRF) 
[199]. CRF represents the conditional probability of the outcome,y ∈ Y given a sequence 
of ICU measurements x = {x1, x2… xT} i.e. p(y|x, θ), where θ is the set of parameters. In 
addition we also assume certain hidden variables h = {h1, h2… hm} derived from the 
combination of features at each time point. The hidden states h take a value from a finite 
set of values given in H. The probability P(y, h|X, θ) is given by (4.2). 
𝐏(𝐲, 𝐡|𝐗, 𝛉) =
𝟏
𝐙
𝐞(𝛉𝛗(𝐲,𝐡,𝐱;𝛉))    (4.2) 
where θ is the set of parameters estimated during training, φ(y, h, x; θ) is the clique 
potential function, and a clique is a fully connected sub-graph [183]. Cliques in a chain 
CRF (used here) consists of an edge between adjacent labels (yt−1 and yt) as well as the 
edges from those two labels to the set of observations x. As a result, CRFs represent the 
conditional probability as (4.3-4.6):  
P(y|x, θ) = ∑
1
Z
e(θ.φ(y,h,x;θ))h     (4.3) 
where, 
Z =  ∑ e(θ.φ(y,h,x;θ))y,h     (4.4) 
φ(𝑋, ℎ, 𝑌; 𝜃) = ∑ ∑ 𝑓𝑙




𝑗=1  +  ∑ ∑ 𝑓𝑙






where, 𝐸, 𝐹 are the number of edges and features respectively. And 𝑓𝑙
1, 𝑓𝑙
2 are 
feature transformation functions (analogous to regression here). Hence, the likelihood 
function is given by equation 4.3 
𝑃(𝑌|𝑋) =  
1
𝑍(𝑋)
×∏ 𝑒𝑥𝑝 (∑ φ(𝑥𝑖, ℎ, 𝑦𝑖; 𝜃)ℎ )
𝑛
𝑖=1    (4.6) 
The log-likelihood is maximized to learn the parameters θ. The inference is done 
by forward-backward inference to obtain the outcome probability from the graph. Over-
fitting of the CRF model is prevented by L1 regularization of weights (the absolute values 
of weights are penalized). The optimization of the hyper parameters such as the number of 
hidden states and the L1 regularization coefficient was performed with 3×3 nested cross-
validation [147]. 
4.2.4 Combining Static & Temporal Models using Hard & Weighted Voting 
The decision values and decisions from the 3 classifiers were combined using hard 
and weighted voting techniques. We tested a total of four different methods to combine the 
decision or decision values. In the first method (M1), combined the three classifiers by 
hard voting where the majority value of the decision (mode of the three decisions) was 
used as the label. In the second method (M2), we used the mean of the decision values from 
the three classifiers to get a new decision values which was used to compute the label. The 
next two methods involved weighted voting, where we first weighted the decisions. The 
weights for each classifier was computed as follows (4.7) 
𝑊𝑒𝑖𝑔ℎ𝑡 = log (
𝐶𝑙𝑃𝑒𝑟
1−𝐶𝑙𝑃𝑒𝑟
)     (4.7) 
where 𝐶𝑙𝑃𝑒𝑟 is the classifier performance (Matthews Correlation Coefficient 
(MCC) scaled between 0 and 1). The decision values (M3) was computed as a weighted 
average of the decisions. This decision value was used to obtain the final label. In the last 
 
 102 
method (M4), the weights for each classifier was obtained using (8). The final decision 
value was the weighted average of the individual classifier decision values. The computed 
decision value was then used to compute the final label.  
4.2.5 Evaluation of the Classification Methods 
The evaluation of all the combination methods was performed using 10-fold cross 
validation. We repeated the process 3 times and report averaged values of Matthews 
correlation coefficient (MCC) and accuracy. We chose MCC as a metric because of its 
relative tolerance to an imbalanced population. 
4.3. Results 
4.3.1 Case Study: Adult ICU Database 
Data Source – MIMIC-II Database 
This study is a retrospective data analysis using data from Multi-parameter 
Intelligent Monitoring in Intensive Care, second version, (MIMIC-II) database. MIMIC-II 
is a public ICU data repository with 32,331 adult and 8,080 neonatal records [149], 
mentioned in the previous chapters. The features included physiological measures (e.g. 
heart rate, blood pressure), lab results (e.g. while blood cells, red blood cells, cholesterol), 
administrative data (e.g. length of stay), diagnostic codes (ICD-9), and comorbidities 
(Table 4.1).  
Table 4.1: Top 5 Feature Types in Dataset. 
Data Type Examples of Measures 
Demographics Gender, Age, Height, Weight, Ethnicity, Comorbidity 
Lab Data Urea, Albumin, Bilirubin, Creatinine, Sodium 




This dataset contains 2,334 patient records with mortality during the ICU stay and 
29,997 patient records of successful discharge from the ICU. Similarly, 7,787 patient 
records had an ICU readmission within 30 days and 24,544 patients did not relapse into the 
ICU within 30 days. As mentioned above, we first performed classification using static and 
temporal classification methods and then combined the decision values and decisions using 
voting methods. 
 
Results for Adult ICU Data to Predict ICU Mortality and ICU-Readmission 
The results from individual classifiers and the combined models are shown in 
Tables 4.2 and 4.3. Our results indicate that the combination models outperformed the 
individual models when using both MCC and accuracy as the metrics for the endpoint of 
mortality. The methods of combining decision values and weighted voting methods have 
the best MCC. The best performing combination models give an improvement in MCC of 
6-7% over logistic regression, 2% over neural networks and 3-8% over conditional random 
fields for mortality. For 30 day ICU readmission, all the combination models performed 
better than the static models for both imputation techniques used. For Imp2, the temporal 
models performed better than the combination models. When MCC was used as the metric 
for comparison, the methods of combining decision values and weighted voting methods 
gave the best performance. The best performing combination models give an improvement 
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in MCC of 33% over logistic regression, 25-26% over neural networks and 26% over 
conditional random fields for Imp1. The readmission models with Imp-2 performed better 
than combination models for ICU readmission.  
4.4. Conclusion and Key Innovations 
Prediction models for clinically significant end-points such as ICU readmission 
remain challenging with limited efficacy in a wide variety of patients.  In addition, ICUs 
also collect data at different frequency rates. In this work, we combine static models, such 
as logistic regression and feedforward neural networks, with temporal models such as 
conditional random fields (CRF), by hard and weighted voting techniques. The combined 
models gave a better performance as compared to individual models. The weighted models 
Table 4.4: Classification Results from ICU Mortality (Mathews Correlation 
Coefficient) (LR = Logistic regression, NN = Neural networks, CRF = Conditional 
random fields, M1 = Voting, M2 = Mean of decision values, M3 = Weighted mean of 
decisions, M4 = Weighted mean of decision values). 
 
Imputation LR NN CRF M1 M2 M3 M4 

























































Table 4.3: Classification Results from ICU Readmission (Accuracy) 
(LR = Logistic regression, NN = Neural networks, CRF = Conditional random fields, 
M1 = Voting, M2 = Mean of decision values, M3 = Weighted mean of decisions, M4 
= Weighted mean of decision values) 
  Imputation  LR NN CRF M1 M2 M3 M4 



























































where the proportion of the decision making was based on individual performances gave 
the best overall performances. We can conclude that combination of multiple model types 
with different feature types improves the robustness of the model for complex data types 
and hence has the potential to enhance immediate management of a patient and the overall 
resource utilization.  
Our work, currently combines data from only adult patients from MIMIC-II and 
also does not include high frequency data such as waveform data. In the future we aim to 
overcome these challenges and demonstrate our results on pediatric data from Children’s 
Healthcare of Atlanta after IRB approval. We also aim to combine intermediate features 
using deep-learning approaches. 
 To summarize, the key innovations of this chapter include: 
• Combination of static and temporal data for mortality and 30 day ICU readmission. 





DEEP MODELS FOR INTEGRATING TEMPORAL DATA WITH 
STATIC DATA TO PREDICT ICU LENGTH OF STAY IN 
CHILDREN  
5.1. Introduction 
 The long length of stay (LOS) in the hospitals and intensive care unit (ICU) is a 
key contributing factor towards the higher cost of healthcare and is associated with long-
term adverse effects such as neuro-developmental disorders for young kids [18]. Patients 
with an ICU stay longer than seven days utilize more than 50% of the ICU resources [200]. 
Studies have shown that factors such as intensivist consultation and admission standards 
[201], improved sedation practices, oxygen therapy for high-risk surgical patients[202], 
and effective communication [200] have been instrumental towards reducing ICU lengths 
of stay. Hence, the identification of patients at risk for a longer ICU stay is essential for the 
effective allocation of resources. 
 The ICU is a complex environment with large amounts of multimodal, multi-time 
resolution data collected for each patient visit. ICU data is collected in electronic health 
records (EHR) systems at multiple temporal resolutions and can be categorized as static/ 
non-temporal, temporal, and continuous waveform. Static data does not change over the 
patient stay. Temporal data such as clinical parameters, lab tests, and medication change 
several times during a single ICU stay. Continuous waveform data such as 
electrocardiogram, electromyogram, and electroencephalogram have multiple values each 
second. This data collected in EHR systems can be leveraged to predict clinical outcomes 
such as risk for long ICU stay.  
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 Scores which help predict LOS using electronic health record (EHR) data 
(APACHE [203], and SAPS [204]) are primarily multivariate regression-based models. 
These models either use aggregated information or temporal data alone for making 
predictions about ICU outcomes such as length of stay. These models do not combine 
temporal and non-temporal data in the EHR. In this study, we propose the integration of 
temporal data (binned into 2-hour intervals) and non-temporal data using deep-learning 
methods. Temporal data from EHR is used for LOS prediction using long-short-term-
memory networks (LSTM), and non-temporal data is modeled using neural networks. . We 
compared our models against standard classifiers such as k-nearest neighbors (kNN), 
random forests, decision trees, and support vector machines (SVM),  and regression models 
such as linear, SVM, decision trees and random forest regression models We also 
demonstrate the superiority of combination models against the individual models. Finally, 
we focused on a pediatric population which tends to be much more heterogenous and 
under-studied. 
 Longer ICU length of stay is associated with higher risk of life-threatening 
outcomes such as long-term mortality [28, 29, 154], acute kidney injury [21, 29], sepsis 
and severe infections [23, 24]. Any intervention, pharmacologic or procedural, that could 
abbreviate their length of stay in ICU would have a significant impact on the child’s quality 
of life and society’s overall resource utilization [34-36].  
 Current research on ICU LOS use aggregated data and are based on standard 
machine learning techniques such as regression trees [205, 206], support vector machines 
[207, 208], random forests [206, 207], Bayesian methods [208], neural networks [209] and 
kNN [208]. The challenge with these models is that only the first-day data [210, 211] or 
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aggregated models can be used. These challenges are addressed by building temporal 
models such as Markov processes [212] and Cox regression [213]. However, these models 
do not integrate temporal and non-temporal data from LOS prediction.  
 The combination of data at different temporal resolutions (temporal and non-
temporal (static) data) can be performed either at the feature level, the decision level or at 
intermediate feature level [214, 215]. The combination at feature level can be performed 
through aggregation or abstraction of the temporal data, or through repetition of static data 
[216, 217]. The combination at decision level can be performed through hard and soft 
voting principles [218]. However, both these types of combinations do not account for the 
temporality of data and the interaction between the different types of data. In this work, we 
showcase the combination of the two data types using intermediate features through a deep 
learning approach. 
 Deep learning models have shown great potential for prediction in EHR data [114, 
120]. In addition to non-temporal models such as autoencoders [112, 114], deep belief 
networks [219], and restricted Boltzmann machines [117], temporal models such as 
recurrent neural networks (gated recurrent units (GRU) [120], and LSTMs [220]) have 
shown improvement over standard techniques. LSTM models [221], in particular, have 
proven effective in the areas of sequence mining such as natural language processing [222], 
handwriting recognition [223], speech recognition [224], and bioinformatics [225, 226]. In 
EHR data analysis, LSTM and GRU models have been used for the classification of disease 
using both waveform and time-series data with proven improvement over standard machine 
learning [120, 123]. LSTMs are particularly effective for EHR sequence analysis since they 
are capable of handling sequences of varying lengths, can handle long-term and short-term 
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dependencies, and are tolerant towards missing data. Since LSTM networks utilize 
temporal relationships to provide intermediate features, they can be integrated with the 
non-temporal model. Common EHR data analysis methods for non-temporal analysis 
include logistic regression [28, 33, 78], cox regression [78] and artificial neural networks 
[28, 80, 170]. Feed-forward neural networks have been widely used for classification and 
are amenable towards integration with LSTMS. 
 In our analysis, we integrate temporal and non-temporal data for the length of stay 
prediction using pediatric data. For temporal data, we use LSTM models which we 
integrate with neural networks for non-temporal data. We use the models for predicting 
patients at a high risk of LOS >& and for predicting the ICU LOS. We evaluate our 
classification models using metrics of accuracy, Matthews correlation coefficient (MCC), 
precision, recall and F1 scores, and regression models using root mean square error 
(RMSE) and mean absolute error (MAE). . The major contributions of this paper are as 
follows: 
• We developed a framework for combining data from multiple temporal resolutions 
using deep models for classification and regression tasks. 
• We show the effect of using long term associations on the prediction performance 
of LSTM models. 
• We demonstrate ICU length of stay prediction on pediatric ICU patient data 
• We developed perturbation based analysis for data interpretation. 
 We structure the rest of the chapter as follows: we first describe the modeling and 
evaluation framework; followed by the results and discussion. Here where show an 




In this study, we perform a retrospective data analysis using pediatric patient 
records. Since the majority of the ICU resources (> 50%) are utilized by patients with LOS 
greater than seven days we classify the patients with stay longer than seven days from those 
whose stay is lower than seven days. (median ICU stay is 3.8 days) [200]. In addition, we 
also make predictions about the ICU length of stay using regression models. 
5.2.1 Data Description 
Our dataset is from Children’s Healthcare of Atlanta (CHOA) containing 5000 
patient records spanning an 11 month period. The visits spanned pediatric ICU (PIC), 
Neonatal ICU (NICU), and cardiac ICU. Each ICU stay record consists of the patient’s 
demographic information (e.g., gender and age of admission), diagnosis (e.g., ICD-9 
codes), birth-related events (e.g., birth weight, head circumference, gestation weeks), 
microbiology events (e.g., microbes in blood or serum), chart events (e.g., heart rate), 
medication intake events, microbiology events (e.g., microbes), and clinical records (e.g., 
heart rate, oxygenation) collected from bedside monitors, averaged over each min (Table 
5.1.) 
The data columns were binary, categorical and quantitative from which we 
extracted features. We used categorical data such as  the disease codes and procedure codes 
into the number of times each disease or condition was present or the procedure performed. 
Table 5.1: CHOA Data Description 
Data Type Examples of Measures 
Demographics DOB, Gender, Age, Height, Weight, Ethnicity, Religion, Date of Death, 
Co morbidity with other diseases 
Microbiology Types of microbes, Amount of microbes, dilution 
Lab Data Urea, Albumin, Bilirubin, Creatinine, Sodium, Potassium, Calcium 
Medication Data Medication & IV administered, Dosage, Duration time, Concentrations 




This gives us 9,071 non-temporal features consisting of demographics, microbiology, 
diagnosis codes, and medication data. In this dataset, since the temporal information for 
microbiology, medication, and pathology was not available, we treated them as non-
temporal data and performed aggregates over the duration of the stay. The temporal data 
we used was from the various lab tests performed. Lab test data had a median sampling 
interval of 2.05 hours, from which we extracted 2,500 features. After removing features 
with greater than 80% missing data, we were left with 1,882 lab features, which we binned 
into 2 hours binning interval. In addition, this dataset had an issue where the tests or values 
were not recorded for very long time intervals (~ several days) in the middle. This could 
be due to the fact that the patients were no longer in the ICU. We treated this type of data 
as multiple time-series for each patient visit, and did not use the missing period for binning. 
Since non-temporal data has less than 1% data missing no features were removed.  
5.2.2 Data Preprocessing and Feature Selection 
The features were extracted in the previous step were either quantitative real 
numbers or binary. The range of quantitative features had an order of magnitude variation 
(e.g. respiration rate varied from 10 – 30 breaths per min, blood pressure varied from 90-
150 mmHg, and blood calcium varied between 8-11 mg/dL ). To address this issue, we 
normalized all the features between the ranges 1 – 2. We also converted the binary values 
into 1 or 2. Following this, we performed feature selection for temporal data using 
minimum redundancy maximum relevance (mRMR) [227]. We tested for 200, 300 and 400 
features. For mRMR, we used mean interpolation, however in the subsequent analysis, no 
data imputation was used. In the future, we will investigate the use of more sophisticated 
feature selection techniques which can handle partial data, such as mutual information with 
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missing data [228] and margin based feature selection [229]. Following feature selection, 
we proceed to classification with individual classifiers (non-temporal and temporal) 
followed by the integration.  
5.2.3 Length of Stay Prediction using Non-Temporal Data 
We performed the analysis of non-temporal data (features from administrative data, 
demographics, diagnostic codes, microbiology, medication, and pathology) with 9,071 
features using feedforward neural networks. Feedforward neural networks can be defined 
as a function which gives the relationship between input 𝑋 and outcome 𝑌 (length of ICU 
stay >7). Each layer of a feedforward neural networks takes an input of dimension 𝑛 ×  𝑑, 
where 𝑛 is the number of samples 𝑑 is the input dimensionality to give z (5.1)  
𝑧 = 𝑠(𝑊𝑥 + 𝑏)    (5.1) 
where 𝑠.is an activation function such as sigmoidal or tanh, [𝑊, 𝑏] are parameters 
to be trained. The inputs are passed through a number of layers till the final layer gives the 
classification output 𝑌. The model parameters are trained using backpropagation on the 
training dataset. We used a total 3 hidden layers and tanh activation function. The size of 
each hidden layer was half of the previous layer. Hyper-parameters such as the network 
size was determined using a grid search. We tested a network size of 2 and 3 layers, with 
the size of each of the first hidden layer 400, 300, 200. 
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5.2.4 Length of Stay Prediction using Temporal Data 
As mentioned above we selected 400 temporal features from lab data, which we 
use to classify the patients into LOS >7 days and those with LOS < 7 days. We used LSTM 
networks for temporal analysis. Several variations of LSTM networks have been proposed 
since their introduction by Hochreiter et. al. The most commonly accepted version of 
LSTM networks today [230, 231] is composed of units called memory blocks, where each 
memory block contains three gates (input, output and forget) and peepholes. Input gates 
are used for regulating (scaling) the input into the memory cells. Output gates are used for 
regulating the outputs to the rest of the network. Forget gates are used for adaptively 
resetting the states within memory cells. Peepholes allow three gate values from within 
each cell to modify the current state within each memory block. The regulation of each 
memory block (Figure 5.1.) is governed by equations 5.2 – 5.8, which are iteratively 
calculated at each time-step in the network. The input at each time instant 𝑡 (𝑥𝑡), is passed 
through the input layer to get the value at the input gate 𝑒𝑡. 𝑒𝑡 is then passed through the 
other 2 gates and using the values at each peephole we get the output 𝑦𝑡+1. 
𝑦𝑡+1 = 𝑠𝑜𝑓𝑡𝑚𝑎𝑥(𝑊
𝑦𝑚𝑚𝑡)    (5.2) 
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𝑓)  (5.7) 
𝑒𝑡 = 𝑊
𝑒𝑥𝑥𝑡     (5.8) 
where ⊙ denotes element-wise multiplication and 𝜎 is sigmoid activation function. 
The 𝑊 terms i.e. (𝑊𝑓𝑒, 𝑊𝑓𝑚, 𝑊𝑓ℎ, 𝑊𝑖𝑒, 𝑊𝑖𝑚, 𝑊𝑖ℎ, 𝑊ℎ𝑒, 𝑊ℎ𝑚, 𝑊𝑜𝑒, 𝑊𝑜𝑚, 𝑊𝑜ℎ, 𝑊𝑚𝑚, 
𝑊𝑦𝑚) are the models weights, and the 𝑏 terms i.e. (𝑏𝑓, 𝑏𝑖, 𝑏ℎ, 𝑏𝑜) are the bias terms. The 
weights and bias form the parameters ([𝑊, 𝑏] of the model, which are obtained during 
training. Training and optimization of the model is performed using Adam optimization 
[232] with a  fifth of the training samples randomly chosen for each epoch.  
 
Figure 5.2: LSTM network. The patient features after feature selection is passed 
through LSTM layer and the intermediate features so generated are then passed 
through a fully connected layer for temporal analysis. 
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 Each LSTM layer consists of 𝑡 = 1 − 𝑇 LSTM units joined and evaluated 
iteratively (Figure 5.2). Our LSTM network consists of multiple LSTM layers, with the 
number of hidden layer in every successive layer half the previous layers. The decision 
made at the last time point is the final output of the LSTM network. For temporal 
prediction, the results of the last time point available for each patient is passed via a linear 
layer followed by a softmax layer. Hyper-parameters such the number of layers and size of 
each layer was estimated using the performance on a validation dataset. We tried  1 ,2 
LSTM layers with the size of the first layer being 128, 64, 32, and 16. 
5.2.5 Integration of Temporal and Non-Temporal Models 
The integration of temporal and non-temporal models are performed through the 
integration of intermediate features generated using the individual models (Figure 5.3). 
Intermediate features are generated from the individual models when the input is passed 
 
























through all layers expect the final classification (linear + softmax layer). These features are 
concatenated using a linear layer followed by a classifier. The classifiers tested for the 
classification layer include k nearest neighbors, random forests, decision trees, and support 
vector machines. 
5.2.6 Model Implementation  
We developed the deep-models on torch lua environment. The libraries used 
included nn, nnx, optim, autograd and rnn. We ran the models on the pace clusters service 
by Georgia Tech (https://pace.gatech.edu/overview). Pace clusters can be accessed by 
writing a short proposal detailing the project and its usage by PIs. Each new student account 
also requires a description of the student’s project, GT ID and a mandatory tutorial. Due to 
a lower number of GPUs as compared to the CPU, we trained our models on CPUs. We 
used 10 CPUs for training the deep models with each epoch taking about 2.5 hours. For the 
baselines, and classification layers, we used matlab2016b also in pace clusters. 
5.2.7 Model Evaluation  
From the total samples, 10% of the data was kept as external test set. Remaining 
data was used for training and validation using 3 fold cross validation. Cross validation 
was used for hyper-parameter evaluation. The temporal classification models were 
evaluated using GRUs (chosen since they are temporal deep models), and standard machine 
learning techniques such as k nearest neighbors, random forests, decision trees, and support 
vector machines. Standard machine learning techniques were used on aggregated data 
(means of the evaluation period). The non-temporal models were evaluated using k nearest 
neighbors, random forests, decision trees, and support vector machines. The integrated 
models were also evaluated against feature level integration techniques. The LOS 
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prediction using a combination of deep models with regression layer was evaluated using 
linear, SVM, decision trees, and random forests regression as baselines The evaluation 
metrics for classification include accuracy, Matthews correlation coefficient, precision, 
recall and F1 scores [233, 234]., and for regression include RMSE and MAE.  
5.2.8 Model Interpretation using Perturbation Analysis 
Interpretability of deep-learning models constitutes a major challenge. Rigorous 
research on the understanding of the representations coded by deep models has led to the 
conclusion that the behavior of deep models are very complex and a direct interpretation 
of the units and layers in the network can give rise to erroneous conclusions [235]. As an 
alternative, predictions/ conclusions from deep layers are passed as inputs to other machine 
learning models for improving interpretability [235]. Since in EHR data analysis, 
interpretation of features is of particular importance, in this work, we interpret the models 
by masking each feature in the classification model and checking for the changes in MCC. 
 
Figure 5.4: Model interpretation pipeline. The features for the deep models are masked 
one at a time and the effect on the classification is observed. The feature which gives 
the highest drop in accuracy is ranked the highest. Once we ranked the features, we 
checked if the intermediate picked associations different from raw data using cluster 
analysis. 










(e.g. CN,MCI, AD) 
Masking 1 Feature at a Time 
Classification with 1 
feature being masked 
for  the best performing 
deep model.
Features which gave the most drop in 
accuracy were ranked higher






The features which gave the highest drop in MCC was ranked higher (Figure 5.4.). We 
report the top features which gave the highest drop in MCC on the test sets.  
 
5.3. Results 
As mentioned above, we demonstrated our results using CHOA dataset with a total 
of 5,739 records. Patients had an ICU length of stay > 7 days in 2,174 records. We utilized 
up to 4 days of lab data (temporal) and demographics, microbiology, pathology, diagnostic 
codes and procedure details to classify which patients were likely to have LOS greater than 
seven days. We also predicted the length for ICU stay for patients with long LOS using 
regression models 
5.3.1 Classification of Patients at Risk of Length of Stay >7 
Non-Temporal Analysis 
We used a feedforward neural network with 1 input layer and 2 hidden layers, 
where the hidden layers had 200 and 100 nodes each. The training of the networks was 
done using Adam with a max epoch count of 10. The classification results in cross 
validation (Table. 5.2a.) indicate that the deep-learning models outperformed kNN, SVM 
and decision trees. Random forests gave the best performance. Despite this, we chose 
neural networks for integration due to the ease of integration and the ability to fine tune the 
integrated models. On the external dataset (Table 5.4), ventilator days, number of billable 
procedures, number of custom disease codes, number of ICD-9 codes, and the number of 
diseases coded final were the top features selected. Number of ventilator days [236, 237]; 
discharge destination [238, 239]; and ICU source [240-242] have been shown to be 




After validation, we used a 2 layer LSTM network with 64 outputs nodes in the 
first hidden layer and 32 output nodes in the second hidden layer of the network. As 
Table 5.2: Classification Cross Validation Result a) Non-Temporal Results b) Temporal 
Results c) Integrated Results. The kNN, SVM , RF and decision trees are baseline models. 
(kNN refers to k-nearest neighbors, SVM refers to support vector machines, RF refers to 
random forests, and IntF is the intermediate features which care combined with the different 
classification layers). 
   
a: Results of non-temporal analysis. The results indicate that random forests outperformed 
deep models and all other baselines. 
  
b: Results of temporal analysis. The results indicate that LSTMs outperformed all baselines 
(kNN, SVM, decision trees, random forests and GRU) 
 
c: Results of integrated analysis. The results indicate that integrated models outperformed 
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mentioned above the input to the network were the 400 selected features. The top features 
which were input into the model included the number of times the cyclosporin, calcium, 
heparin assay, amikacin trough, tacrolimus, state metabolic screen, tobramycin random, 
Table 5.3: Regression Cross Validation Result a) Non-Temporal Results b) Temporal 
Results c) Integrated Results. The linear, SVM, decision trees, and random forests 
regression models which are run on the intermediate features generated using deep 
models and on raw features. (IntF is the intermediate features and RawF are raw 
features). 
     
a: Results of non-temporal analysis. The results indicate that random forest regression 
with intermediate features outperformed deep models and all other baselines. 
      
b: Results of temporal analysis. The results indicate that random forest based 
regression models with raw features outperformed all other models. 
     
c: Results of integrated analysis. The results indicate that random forests based 





























































IntF RMSE IntF MA RawF RMSE RawF MA
 
 121 
soluble IL-2R, IGG, and lidocaine were performed. The training of the networks was done 
using Adam with a max epoch count of 10. For each of the epochs, 1000 samples of the 
training data was selected at random. The cross-validation results (Table. 5.2b.) indicate 
that the deep-learning EHR models outperformed all the standard models and GRUs.  
On the external test set (Table 5.4.), capillary POC pH tests, the number of times 
the specimen was taken, methemoglobin tests, mean platelet volume tests and drug screen 
serum tests were the top features. Blood pH changes [243] [244]; methemoglobinemia 
[245] [246]; and hemoglobin [247, 248] have been shown to be associated with longer ICU 
LOS. 
Integrated Models 
The integrated models used the intermediate features from non-temporal (100 
features) and temporal (32 features), which were added to a classification layer. We tried 
kNN, SVM, decision trees and random forests for the classification layers. Results (Table 
5.2c.) indicate that the integrated models outperformed either of the individual modalities 
for ICU length of stay prediction. The deep models with the classification layer random 
forests outperformed individual models and feature level combinations.  
For imbalanced datasets such the EHR data, MCC is a better measure than of 
performance than accuracy [233]. When we compare the MCC of the best performing 
combined model with the best performing temporal model, we see a 7% change on the 
external test set, with the integrated models performing better. Similarly, we observed a 
3% improvement over non-temporal models.  
On the external test set (Table 5.4.), number of times flu A,B RSV PCR was 
performed, the number of times GRAM STAIN test (check the presence of gram negative 
bacteria) was performed, the number of times the specimen source was abdominal fluid, 
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and the number of times the specimen source was Abscess. The presence of gram negative 
bacteria [249] [250]; abdominal fluid abnormalities [251] [252]; and abscess [240, 253] 
Table 5.4: Top 10 features from classification and regression analysis. The lab data 
consisted of information on the tests and procedures conducted (labeled as component 
name along with the procedure name or the just the test name), the source of specimens 
(e.g. blood serum, urine and labeled as source), and the number of abnormalities in tests 
and procedures performed (labeled as Result status) 
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a) Results of classification analysis.  
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b) Results of regression analysis.  
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has been associated with longer ICU LOS. 
5.3.2 Regression Analysis for Predicting Length of ICU Stay 
For patients at risk for LOS>7, we performed a regression test for predicting the 
actual length of stay. We tried the intermediate features generated using deep-models in 
the previous step against the raw features for predicting LOS using linear, SVM, decision 
trees, and random forests based  regression techniques 
Non-Temporal Analysis 
The regression results in cross validation (Table. 5.3a.) indicate that random forest 
regressions using intermediate features outperformed all other base lines and those using 
intermediate features. The external validation results (Table 5.4) showed that the non-
Table 5.5: External Test Result. For classification deep models outperformed for 
temporal and integrated analysis. For regression, deep models outperformed for non-
temporal and integrated analysis. 
 Models External Test Performance 
Temporal Analysis 
Classification 
LSTM: #features 400, Layer  sizes (64, 
32) Classification Layer: Random Forest 









Random Forest Trees = 100; 
Accuracy: 0.89  
MCC: 0.77 
Precision: 0.88  
Recall: 0.88 
F1 Scores: 0.88 
Integrated Analysis 
Classification 
Deep-Model: Non-Temporal Layer  sizes 
(200, 100) LSTM: #features 400, Layer  
sizes (64, 32) ; classification layer = 





F1 Scores: 0.91 
Temporal Analysis 
Regression 






Deep-Model: Layer  sizes (200, 100); 
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temporal analysis results were the best. On the external dataset (Table 5.4), ICU visit (Y/N) 
(for PICU, NICU, and CICU); number of ventilator days [236, 237]; discharge destination 
[238, 239]; gender [254, 255], glucose abnormalities [256, 257] and ICU source [240-242] 
are top features which have been shown to be associated with longer ICU LOS.  
Temporal Analysis 
The regression results in cross validation (Table. 5.3b.) indicate that random forest 
regressions using raw features outperformed all other base lines and those using 
intermediate features. The external validation results (Table 5.4) also showed that the 
temporal analysis results using only the details of the test performed and the number of 
abnormalities were not as informative as the non-temporal (with demographics, 
medication, procedure and ICD-9 codes) and integrated models for the prediction of ICU 
LOS. On the external test set (Table 5.4.), hematocrit tests [258, 259]; sodium tests [260, 
261]; and blood pH changes [243] [244] are top features which  have been shown to be 
associated with longer ICU LOS. 
Integrated Analysis 
The regression results in cross validation (Table. 5.3c.) indicate that random forests 
regressions using intermediate features outperformed all other base lines and those using 
intermediate features.  The cross validation and the external validation results (Table 5.4) 
showed that the integrated models with deep learning generated intermediate feature gave 
an improved performance for LOS over temporal models. This shows the synergistic 
effects of the integrated models. On the external test set (Table 5.4.), act coagulation 
time[262, 263]; urine RBC tests[258, 259]; blood pH changes [243] [244]; and 
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cerebrospinal fluid protein tests [264, 265] are top features which  have been shown to be 
associated with longer ICU LOS.  
 
5.3.3 Analysis of Temporal Data for Effects of Multiple Time Windows (Long -
Term Memory Component) 
In order to test the effects of using longer term data as opposed to short term data, 
we used a window based approach for the LSTM models. We started backwards with using 
only the fourth day data. Then we progressively increased the window size by adding half 
a day word of data at each step until we reached the end. We performed this analysis for 
both the classification models. For classification, our results (Figure. 5.5a.) indicate that 
the prediction metrics MCC, mean precision, mean recall and mean F1 score steadily 
increased with increased wind size and was the highest when all the data included the first 
time step information was added. This analysis shows the LSTM models trained for LOS 
risk prediction requires long term dependencies for improved decision making as opposed 
to short term dependencies alone. Conversely, for the regression analysis results (Figure. 
5.5b.), the increasing the window decreased the performance. The RMSE and MAE values 
increased when longer term information was used. This shows that the prediction of LOS 
placed higher dependencies on the short term features as opposed to long term relationships 
in data. This is also supported by regression analysis using early versions of LSTMs [266] 
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where window based approaches using smaller windows gave a better performance for 
regression problems as opposed to LSTM networks. In addition, small data sizes may affect 
the performance of LSTMs for regression as well.  
 
a. Classification Results Windowing Analysis: We used upto 4 days of information 
to predict length of stay. We added details of .5 days at a time. (only 3-4 days, 
2.5-4 days, 2-4 days, 1.5-4 days, 1-4 days, .5-4 days and 0-4 days). Adding more 
long-term details improved performance measured using MCC, mean precision, 




b. Regression Results Windowing Analysis: We used upto 4 days of information 
to predict length of stay. We added details of .5 days at a time. (only 3-4 days, 
2.5-4 days, 2-4 days, 1.5-4 days, 1-4 days, .5-4 days and 0-4 days). Adding more 
long-term details did not change performance much but dropped performance 
slightly. Performance was measure using RMSE and MAE 
Figure 5.5: Windowing Analysis. a) Classification analysis b) Regression Analysis 
(MCC refers to Matthews correlation coefficient, RMSE refers to root mean square 
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5.3.4 Analysis of Intermediate Features from for Data Associations not Seen in 
Raw Data. 
In addition to the tests for the effects of short term and long term dependencies on 
the model performance, we also evaluated the intermediate features generated from the 
deep models using a cluster analysis. This was performed to check for data relationships 
picked by the deep models which are not easily discernible in the raw features. For this 
analysis, we clustered the intermediate features (training set) from temporal and non-
temporal models using kmeans. We used the training data to fix the number of clusters and 
cluster centers. Then we map the test data to the same cluster centers. Then we check if the 
separation of intermediate features into clusters or the lack is consistent across training and 
test samples. The cluster number was evaluated using the mode of cluster number 
generated using Calinski Harabasz [267], Davies-Bouldin [268], silhouette [269] and gap 
scores [270]. For both the non-temporal and temporal data, we clustered the intermediate 
  
a     b 
Figure 5.6: Cluster analysis results: Temporal data. a) gives the intermediate features 
plotted against the top ranked features which discriminated the two clusters using 
relieFF. b) gives the original data plotted against the top ranked features which 
discriminated the two clusters using relieFF  
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features generated. We test a cluster number of 2-20 to pick the optimum cluster number, 
which was found to be two. We plotted the intermediate features and the original data 
against the top features (relieFF) which discriminated the two clusters (Figure 5.6a,b, 
5.7a,b). We found that the intermediate features generated better separation as compared 
to the original data. This indicates that the intermediate features found relationships which 
are not easily apparent in original data.  
In summary, ours results indicate the following 
• For classification of patients into those with a risk for long length of ICU 
stay, LSTM based models gave best performance for temporal data alone, 
random forest based models gave an improved performance for non-
temporal data alone. In the presence of both data types, the integrated 




a     b 
Figure 5.7: Cluster analysis results: Non-Temporal data. a) gives the intermediate 
features plotted against the top ranked features which discriminated the two clusters 
using relieFF. b) gives the original data plotted against the top ranked features which 
discriminated the two clusters using relieFF 
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• For the prediction of numerical LOS, deep models were beneficial when 
non-temporal data available and when both data types were available. With 
only temporal data type, random forest based techniques on raw data gave 
the best performance. 
• To determine risk of long LOS, the long term temporal dependencies give 
improved predictive performance. To the prediction of numerical LOS, 
short term dependencies were found to be more meaningful. 
 
5.4. Conclusion and Key Innovations 
Most common models for ICU length of stay (LOS) are based on the use of static 
or temporal data In this study, developed deep-learning strategies for the integration of 
static and temporal ICU data. We utilized an LSTM based approach for temporal data and 
neural networks for non-temporal data. The combination was performed using a 
classification layer/ regression layer. We evaluated our models on pediatric data from 
CHOA by comparing our models using gated recurrent units, random forests, support 
vector machines, k nearest neighbors, and decision trees. Using accuracy, Matthews 
correlation coefficients, precision, recall, and mean F1 scores as evaluation metrics, our 
integrated models outperformed all baselines for predicting long ICU stay. The integrated 
models using deep models also outperformed the shallow learned and the individual 
modalities for the prediction of the actual length of ICU stay. 
However, despite good prediction, our model suffers from the challenges in 
interpretability. In this analysis, we address this partially using a perturbation-based 
approach to interpret the intermediate features generated using deep learning. In the future, 
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we will extend this work to include more interpretability by following a sequential feature 
selection based approach and adding features sequentially and a back propagation based 
method. In addition, in our current work, we used the intermediate feature generated for 
classification to perform regression. Though this shows the generalizability of the features 
extracted, we may be able to show improvements in performance by using a dedicated deep 
regression model in the future. We will also investigate the use of more window based 
regression techniques such as ARMA and ARIMA [266] in our analysis. We will also 
extend our analysis to include more end-points such as ICU readmission, and ICU 
mortality. 
We will also investigate the use of more sophisticated feature section techniques 
such as mutual information with missing data [228], margin based feature selection [229], 
time series feature[271] selection which is robust to missing time series data. 
 To summarize, the key innovations of this chapter include: 
• We developed a framework for combining data from multiple temporal resolutions 
using deep models. 
• We demonstrate ICU length of stay prediction on pediatric ICU patient data 
• We developed perturbation based analysis for data interpretation. 





 DEEP LEARNING MODELS FOR INTEGRATING ELECTRONIC 
HEALTH RECORD DATA WITH GENETIC DATA FOR 
ALZHEIMER’S DISEASE PREDICTION 
6.1. Introduction 
 Alzheimer’s disease (AD) is the most common neurodegenerative disorder [272] 
and forms the 6th leading cause of death in the United States. There are more than 5.3 
million people living with Alzheimer’s in the United States alone [273, 274]. In addition, 
the mortality caused by AD has steadily increased over past 30 years, contributing to over 
83,494 deaths in 2010 [275]. The healthcare cost for AD is also steadily increasing. It was 
estimated to be 200 billion dollars in 2012 and is expected to be 1.1 trillion dollars by 2050 
[275]. Despite extensive research and advances in clinical practice, there is still a lack of 
complete knowledge regarding the biomarkers which are indicative of AD and its stages. 
Less than 50% of the people with AD are being diagnosed accurately for their pathology 
and disease progression on the basis of their clinical symptoms [273]. The presence of 
amyloid plaques and neurofibrillary tangles in histopathology is the most conclusive 
evidence for Alzheimer’s diagnosis. However, the early onset of AD is not correlated with 
the presence of plaque but with synaptic and neuronal loss [276]. 
 Research on data from Alzheimer’s disease initiative [277] and data mining 
strategies [278-282] for AD are being undertaken to improve our understanding of the 
underlying disease processes. AD biomarkers including clinical symptoms (such as 
dementia, memory loss), neurological tests [283] and scores such as MMSE scores[284] 
are being augmented with several imaging, genetic and protein related biomarkers. 
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Cerebrospinal fluid-based biomarkers such as Aβ1-42 levels (indicative of amyloid 
deposition in the brain) [285], total tau protein and hyperphosphorylated tau protein [286], 
YKL-40 chromogranin A, and carnosinase I [287] have been shown to be well-accepted 
markers indicative of early and advanced AD. Similarly imaging markers such as white 
matter hyperintensities [10], volume reductions of the medial temporal lobes (indicative of 
neuronal loss and accumulation of neurofibrillary tangles), pathological involvement of 
limbic and cortical regions [288], and changes in hippocampus volume and structure [289] 
have been identified using positron emission tomography (PET) and magnetic resonance 
imaging (MRI) studies. Research is being undertaken on blood-based biomarkers such as 
blood proteins, circulating miRNAs, small endogenous RNAs [290] to find relatively non-
invasive biomarkers. However, most of these studies identify biomarkers using a single 
modality or data type. This limits the ability of the data mining algorithms to find more 
generalized biomarkers and subsequently the mechanisms indicative of AD. Use of such 
limited datasets (hence bio-markers) also restricts the performance of these algorithms for 
the early identification of AD disease and its stages. In addition, most of these studies 
perform binary classification into either AD/MCI vs controls or AD vs controls. 
 Current multi-modal analysis for AD mostly combines various imaging modalities 
[291-295] such as structural MRI (T1 weighted, T2 weighted, DTI, DWI), fMRI and PET 
[296, 297]. Another established multi-modal analysis for AD is imaging genetics [298]. 
However, these studies mainly use traditional machine learning techniques such as t-tests 
[292], support vector machines (SVMs) [291], and principal component analysis 
(PCA)[299], which may not take full advantage of integration of different data. In addition, 
these techniques fail when the data for particular modalities are absent. The recent 
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advances in deep learning [300] and their applications to Alzheimer’s imaging data [301-
303] have shown promising results in improving upon the prediction power of the AD 
models. Deep learning based image fusion studies using PET and MRI data also report 
improved predictive performance with auto-encoders [304, 305], and deep-belief networks 
[306]. Deep-learning studies for EHR [120] and SNP [307] data have also shown 
improvement over traditional machine learning.  In addition, the use of deep-learning 
techniques also facilitates the training and prediction in the presence of partial data [308].  
 In this study, we further the multimodal AD data fusion to advance AD stage 
prediction by using DL to combine imaging, electronic health record and genomic SNP 
data for the classification of patients into control, MCI, and AD group. We use stacked de-
noising auto-encoders for EHR and SNP data respectively, and novel 3D convolutional 
neural networks to train MRI imaging data. After the networks are separately trained for 
each data modality, we combine them using different classification layers including 
decision trees, random forests, support vectors machines (SVM) and k-nearest neighbors 
(kNN). We demonstrate the performance of our integration models using the ADNI [309] 
dataset that contains SNP (808 patients), imaging (MRI) data (503 patients), and clinical 
and neurological test data (2,004 patients).  
 Despite superior performance in clinical decision support using multiple data types, 
a major drawback for widespread adoption of DL models for clinical decision making is 
the lack of well-defined methods for interpreting the deep models. We address this 
challenge by developing novel perturbations and clustering-based approach for finding the 
top features contributing to the decision.  
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 In this study, we report the major contributions for the AD stage prediction as 
follows : 
• Novel DL architectures outperform shallow learning models; 
• Multi-modality data analysis with DL outperforms single-modality DL models; and 
• Novel interpretable DL methods are capable of extracting top performing features. 
 
6.2. Methods 
6.2.1 Data Description 
 This study uses Alzheimer’s Disease Neuroimaging Initiative* (ADNI) database 
(adni.loni.usc.edu) [309] data for the analysis. The primary goal of ADNI has been to test 
whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), 
other biological markers, and clinical and neuropsychological assessments can be 
combined to measure the progression of mild cognitive impairment (MCI) and early 
Alzheimer’s disease (AD). ADNI data repository contains imaging, clinical and genetic 
data for over 2,220 patients spanning over 4 studies (ADNI1, ADNI2, ADNI GO, and 
ADNI3). In our study, we focus on ADNI1, 2 and GO because ADNI 3 is an ongoing study 
which is due to end in 2022. The data is currently being released in phases with limited 
availability for imaging (unprocessed) and no genetic data yet. The imaging data (ADNI1, 
2 and GO) consists of MRI and PET images, of which we use cross-sectional MRI data 
corresponding to the baseline screenings from ADNI1 (503 patients). The images have 
been standardized by the publisher of the data to eliminate the non-linearities caused by 
the scanners from different vendors. For clinical or EHR data, we use 2,004 patient 
(ADNI1, ADNI2, and ADNI GO) data from the clinical tests (e.g. memory tests, balance 
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tests, cognitive tests), medication data (e.g. usage of levodopa), imaging score summaries 
(e.g. levels of FDG from PET, brain volumes from MRI), patient demographics (e.g. age, 
gender), and biochemical tests. The genetic data we use consists of the whole genome 
sequencing (WGS) data from 808 ADNI participants. The WGS has been performed on 
818 subjects (at the time of sequencing, 128 with AD, 415 with MCI, 267 controls and 10 
of uncertain diagnosis) from the ADNI study by Illumina’s non-CLIA laboratory at roughly 
30-40x coverage in 2012 and 2013. The resulting variant call files (VCFs) have been 
generated by ADNI using Broad best practices (BWA and GATK-haplotype caller) in 
2014. Hence for this study, we use a total 2,004 patients for whom clinical data was 
Table 6.1:  1a. Description of ADNI data. Clinical data consists of demographics, 
neurological exams and assessments, medications, imaging volumes and biomarkers. 1b 
Number of patients by modality and disease stage.  (CN: controls; MCI: Mild Cognitive 
disorder and AD: Alzheimer’s Disease). 1c Venn diagram showing the degree of overlap 
between the three modalities. 220 patients had all the three data modalities, 588 patients 




Example Data Types/ Features 
Clinical 
Data 
Demographics, neurological exams, cognitive 
assessments, bio-markers (e.g. alanine, choline), 
medication (e.g. levodopa), imaging summary 
scores (e.g. brain are volumes) 
Imaging Cross-sectional MRI data 
Genetic Whole genome sequencing (WGS) data 
a: 
 
CN MCI AD 
Clinical Data 598 699 707 
Imaging 132 104 266 





EHR: N = 2004
SNP: N = 808
Image: 




available, 503 patients with imaging data (9108 voxels per patient distributed over 18 
slices, with each slice having 22×23 voxels), and 808 patients with genetic data (Table 
6.1.). For participants with multiple visits,  we use the diagnosis from patient’s last visit. 
As shown in Table 6.1c., 220 patients have all three data modalities, 588 patients have SNP 
and EHR, 283 patients have imaging and EHR, the remaining patients have only EHR data
 Most participants in ADNI1/GO/2 studies have multiple visits during the 48 month 
study period. The diagnosis of some of the patient's changes along time. However, in this 
study, we only focus on predicting the risk of developing AD instead of the progression of 
AD. To remove the influence of disease progression, we match the labels based on 
following rules: We only use the diagnosis of each patient’s last visit. This will give us the 
latest label of the patient. 
For labels representing the progression, we map them to following three corresponding 
labels: (1) control (CN), (2) mild cognitive impairment (MCI), and (3) Alzheimer’s disease 
(AD). The detailed label mapping rules are summarized in Table 6.2.  
6.2.2 Data Pre-processing 
 As mentioned above, ADNI dataset consists of MRI imaging data, clinical data, 
and SNP data. For each data modality, we perform feature extraction and selection 
respectively.  
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MRI Imaging Data 
We first preprocess the 3D images to filter noise, perform skull stripping, segment 
different types of brain tissue, normalize and co-register the images to MNI space (Fig 4a.) 
[310]. Following that, we extract 3D areas of 21 brain regions (associated with Alzheimer’s 
disease) including the right amygdala, left and right angular, left and right cerebellum, left 
and right Hippocampus, left and right occipital regions, and left and right superior temporal 
regions (Supplementary material).  
Clinical Features 
From ADNI1, ADNI2, and ADNI GO, we extracted common fields, from which 
we extracted 1,680 features. The clinical features found in this dataset were either 
quantitative real numbers, binary and categorical. We normalized the quantitative data to 
the range 1-2 and converted the categorical data into binary using one hot encoding. We 
also converted all the binary data into values 1 or 2.  
Genetic Data 
Each subject has about ~3 million SNPs in the raw VCF file. To eliminate irrelevant 
and redundant SNPs, we apply multiple filtering and feature selection steps. We first 
eliminate SNPs with 1) low genotype quality, 2) low minor allele frequency, 3) high per 
site missing rate, and 4) significant Hardy-Weinberg equilibrium p value. After filtering, 
we apply a two-stage feature selection. In the first stage we only retain SNPs that located 
on known AD associated genes. In the second stage, we further reduce the number of SNPs 
using minimum redundancy maximum relevance (mRMR) [198]. After feature extraction 
and selection, we obtain 500 SNP features for further analysis. Following feature selection 
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and reduction, we proceed to perform classification of the data into AD, MCI, and controls.  
6.2.3 Intermediate Feature Generation using Individual Modalities 
After feature selection, we use deep-learning techniques for the generation of 
intermediate features. The intermediate features generated from the individual modalities 
are subsequently used for multi-modal analysis. The intermediate features from EHR and 
SNP data are generated using auto-encoders. 
Intermediate Features for EHR and SNP Data using Auto-Encoders  
Each patient data (EHR and SNP) is represented as a vector of length 𝑚 (where 𝑚 is the 
number of features), and is used as an input to the feature learning algorithm. This data is 
then passed through a two-layer stacked denoising auto-encoder network [311] (Figure 6.1) 
to obtain a high level representation of the patient data. Each auto-encoder layer takes an 
input 𝑥 of dimension 𝑛 × 𝑑, where 𝑛 is the number of training samples and 𝑑 is input 
dimensionality (𝑑 = 𝑚 for first layer). The input for each layer is first passed through an 
encoder to convert the input into a higher order representation of the data (6.1).  
𝑦 = 𝑓(𝑊𝑥 + 𝑏)     ( 6.1) 
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where 𝑓 is an activation function such as sigmoidal or tanh, [𝑊, 𝑏] are parameters to be 
trained. The mapped values (𝑦) are then passed through a decoder to obtain a 
representation of the input(𝑥) (6.2).  
?̂? = 𝑓(𝑊𝑇𝑦 + 𝑏′)     ( 6.2) 
where 𝑏′ needed to be trained, and the weights 𝑊𝑇 are tied with the encoder weights. 
The network is constructed by stacking the trained encoder layers. Denoising is 
implemented using dropouts where a portion of the input values are masked (set to zero) 
to allow better generalization of the models in the presence of small and noisy training 
data. Training is performed by back propagation by minimizing the average cross-entropy 
between the input and the reconstructed input data (6.3). 
[𝑊, 𝑏, 𝑏′] =  arg𝑚𝑖𝑛 
[𝑊,𝑏,𝑏′]
− ∑ [𝑥𝑘𝑙𝑜𝑔?̂?𝑘 + (1 − 𝑥𝑘) 𝑙𝑜𝑔(1 − ?̂?𝑘)]
𝑎
𝑘=1    ( 6.3) 
where 𝑎 is number of dimensions. Optimization is carried out using Adam optimization 
[232]with a batch size of three.  
After the training of auto-encoder layers, the network fine-tuning for each modality is 
 
Figure 6.1: Auto encoder layers 
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performed by adding a softmax layer which predicts the final class. The intermediate 
features are the output of the fine-tuned network after removing the softmax layer. The 
hyper-parameters in the model such as the layer sizes, dropout parameters, and 
regularization coefficients are optimized using 10-fold cross-validation. 
Intermediate Features for Imaging Data 
First, we select the regions of interest and put them into a separate 3-dimensional 
convolutional neural network (Fig A2. in the supplementary material) with their weights 
shared across the CNN modules. CNN modules can extract higher level features from the 
abstraction of images to form concepts, that often correlate better with the targets. Each 3D 
CNN in the architecture above comprises 10 3D-convolutional kernels of size 5 × 5 × 5 
followed by pooling layers with pooling kernels of size 3 × 3 × 3. After the pooling layer, 
we feed the pooled 3D images into Rectified Linear Unit (ReLU) non-linearities to learn 
complex features from the input modalities. We use volumetric batch normalization [312] 
that is an effective regularizer for convolutional neural networks. Next, the feature maps 
generated by each 3D CNN are flattened and fed into separate fully connected layers with 
ReLU activation functions, followed by drop-out regularizers. We integrate the features 
generated from each modality and feed them into the second level fully connected layer 
and the corresponding drop-out layer. Finally, we use a softmax layer with a negative-log-
likelihood loss function to train the imaging network.  
We use the combined features generated from the first level fully connected layers 




6.2.4 Multimodal Data Integration 
Data integration across modalities is increasingly being proposed as a method for 
bridging the gaps in our understanding of disease processes, and for improving clinical 
outcome predictions and the model performance. The integration of the data from different 
modalities can be performed at multiple levels (raw feature level, intermediate feature 
level, and decision level) and can follow different approaches during integration 
(concatenation- based integration, transformation based integration, and model-based 
integration)[313] (Figure 6.2). In this study, we propose an integration of the intermediate 
features (transformation based integration) generated in the previous step using a 
concatenation layer followed by a classification layer to get the Alzheimer’s stage (Figure 
6.3.). We tried k-nearest neighbors, decision trees, and support vectors machines  as 
alternatives for the classification layer. In the event any modality was missing for a specific 
patient, we masked the modality with zeros. We evaluated our models using feature level 
combinations and decision level combinations as the baseline models.  
 
Figure 6.2: Deep Model for Data Integration Compared with Shallow Models of Data 
Integration.  a) Feature level integration on shallow models, where the features are 
concatenated before passing into shallow models. b) Deep intermediate feature level 
integration where the original features are transformed separately using deep models 
prior to integration and prediction. c) Decision level integration where voting is 
performed using decisions of individual classifiers.  In this study, we compare the 
performance of deep intermediate level integration against shallow feature and 
decision levels integrations for the prediction of Alzheimer’s stages. 
Imaging EHR SNP
Concatenated Features




Intermediate Feature Level Combination






6.2.5 Model Implementation  
We developed the deep-models on torch lua environment. The libraries used 
included nn, nnx, optim, and autograd. We ran the models on the pace clusters service by 
Georgia Tech (https://pace.gatech.edu/overview). Pace clusters can be accessed by writing 
a short proposal detailing the project and its usage by PIs. Each new student account also 
requires a description of the student’s project, GT ID and a mandatory tutorial. Due to a 
lower number of GPUs as compared to the CPU, we trained our models on CPUs. We used 
 
Figure 6.3: Intermediate-Feature-Level Combination Deep Models for Multimodality 
Data Integration for Clinical Decision Support. Data from diverse sources, imaging, 
EHR and SNP are combined using novel deep architectures. 3D convolutional neural 
network architectures used on 3D MR image regions to obtain intermediate imaging 
features. Deep stacked denoising autoencoders are used to obtain intermediate EHR 
features. Deep stacked denoising autoencoders are used obtain intermediate SNP 
features. The 3 types of intermediate features are passed into a classification layer for 




11 CPUs for training the deep models with each epoch taking about 1 min. For the 
baselines, and classification layers, we used matlab2016b also in pace clusters. 
6.2.6 Model Evaluation 
We first removed 10% of the data as an external test set. On the remaining 90%, 
we performed 10-fold cross-validation to optimize our models (hyper-parameters) as well 
as the baselines. For the integrated models, we evaluated the combination models. We test 
the integration models against feature and decision level combination as baselines. While 
testing individual classifiers, we use k-nearest neighbors (kNN), one-vs-one coding SVM, 
random forests, and decision trees as baselines. For each of the models and the baselines, 
we report mean values of accuracy, precision, recall, and meanF1 scores. 
6.3. Results & Discussion 
As mentioned above, we demonstrated our results using ADNI dataset to show the 
improvement in the prediction when using deep models for individual modalities and the 
improvements gained from data integration. 
6.3.1 3D Convolutional Neural Network (DL) is Superior to Shallow Models on 
Imaging MRI Data  
One patient’s imaging data consists of 9108 3D voxels of dimension 22×23×18, 
corresponding to each of the 5 selected brain areas. The number of nodes in DL models for 
the first-level fully connected layers = 5×20 = 100 and the number of nodes for the second 
level fully connected layer is 20. The results (Table 6.3a.) indicate that the CNN based 
imaging models outperform shallow models and give the best precision and meanF1 scores.  
6.3.2 Deep Autoencoder Model is Comparable to Shallow Models on EHR Data  
EHR data consists of 2,004 patients with 1,680 normalized features per patient, 
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which we use to classify the patients into AD, MCI, and controls (three class). We use a 
three-layer auto-encoder with 200, 100 and 50 nodes each. The training of the DL networks 
is done using Adam with a max epoch count (repetition of DL network training on the 
entire dataset to allow adequate training) of 25. After hyperparameter optimization, the 
regularization coefficients for initial training is fixed at 0.03 and those for fine tuning at 
0.03. The dropout probability is set to 0.6 for all the layers. The results (Table 6.3b.) 
indicate that the autoencoders outperform shallow models such as kNN and SVM, and they 
are comparable to decision trees and random forests.  
6.3.3 Deep Autoencoder Model is Superior to Shallow Models for SNP Data 
Processed SNP data consists of 808 patients with 500 features (each with levels 
1,2,3), which we use to classify the patients into AD/MCI vs controls (two class). Auto-
encoder network consists of three hidden layers with 200, 100 and 50 nodes each.  Using 
Adam optimization and a max epoch count of 30, the best performing models have 
regularization coefficients for initial training as 0.03 and those for fine tuning at 0.06. The 
corruption (dropouts) is 0.6 for each layer. The results (Table 6.3c.) indicate that the auto-
encoder models outperform all the baselines models.  
6.3.4 Results for Multi-Modality Classification 
The intermediate features generated from the single-modality deep-models are 
concatenated and passed to an additional classification layer for integration. 
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Combination of all 3 modalities: (Imaging + EHR + SNP): Deep Model Outperforms 
Table 6.3:: Internal Cross Validation Results for Individual Data Modality to Predict 
Alzheimer’s Stage a) Imaging Results: Deep learning prediction performs better than 
shallow learning predictions b) EHR Results: Deep learning outperforms shallow 
models kNN and SVM and is comparable to decision trees and random forests c) SNP 
Results: Deep learning outperforms shallow models. The kNN, SVM , RF and decision 
trees are shallow models. ((kNN: k-Nearest Neighbors, SVM: Support Vector 
Machines, and RF: Random Forests). 
    
a: Alzheimer disease stage prediction using imaging modalities to predict CN vs AD. 
Convolutional neural networks (DL) outperformed all shallow models.  
     
b: Alzheimer disease stage prediction using EHR modalities to predict CN vs MCI vs 
AD. Auto encoder networks (DL) outperformed shallow models kNN and SVM and 
was comparable to decision trees and RF. 
     
c: Alzheimer disease stage prediction using SNP modalities to predict CN vs MCI/AD. 
Auto encoder networks (DL) outperformed all shallow models.  
 
Metrics kNN SVM Decision Trees RF Deep Model
Accuracy CN vs AD 0.81 ± 0.05 0.82 ± 0.09 0.82 ± 0.06 0.81 ± 0.08 0.86 ± 0.04
Precision
CN 0.78 ±0.12 0.82 ±0.09 0.82 ±0.14 0.81 ±0.1 0.92 ±0.08
AD 0.85 ±0.11 0.84 ±0.13 0.82 ±0.1 0.82 ±0.13 0.80 ±0.1
Recall
CN 0.83 ±0.14 0.81 ±0.15 0.79 ±0.11 0.80 ±0.14 0.85 ±0.08
AD 0.80 ±0.1 0.84 ±0.12 0.85 ±0.09 0.84 ±0.11 0.89 ±0.1
MeanF1
CN 0.79 ±0.06 0.80 ±0.1 0.79 ±0.08 0.80 ±0.07 0.88 ±0.04















Accuracy Precision Recall F1 Scores
kNN SVM Decision Trees RF Deep Model
Accuracy
CN 0.67 ± 0.04 0.84 ± 0.03 0.9 ± 0.02 0.88 ± 0.03 0.83 ± 0.07
MCI 0.65 ± 0.03 0.73 ± 0.02 0.79 ± 0.02 0.76 ± 0.04 0.74 ± 0.06
AD 0.78 ± 0.04 0.81 ± 0.02 0.82 ± 0.01 0.83 ± 0.03 0.85 ± 0.03
Precision
CN 0.51 ±0.03 0.77 ±0.04 0.84 ±0.04 0.81 ±0.05 0.75 ±0.12
MCI 0.56 ±0.06 0.61 ±0.03 0.76 ±0.02 0.67 ±0.05 0.65 ±0.09
AD 0.86 ±0.07 0.77 ±0.03 0.73 ±0.02 0.79 ±0.05 0.84 ±0.07
Recall
CN 0.88 ±0.09 0.77 ±0.08 0.91 ±0.03 0.84 ±0.05 0.76 ±0.27
MCI 0.36 ±0.07 0.64 ±0.05 0.58 ±0.07 0.66 ±0.07 0.65 ±0.12
AD 0.61 ±0.08 0.74 ±0.05 0.84 ±0.05 0.77 ±0.05 0.79 ±0.05
MeanF1
CN 0.64 ±0.03 0.77 ±0.05 0.87 ±0.03 0.82 ±0.04 0.72 ±0.23
MCI 0.44 ±0.06 0.62 ±0.03 0.66 ±0.05 0.66 ±0.05 0.64 ±0.05






















Accuracy CN vs AD/MCI 0.68 ± 0.04 0.72 ± 0.07 0.69 ± 0.06 0.7 ± 0.04 0.89 ± 0.03
Precision
CN 0.51 ±0.27 0.53 ±0.1 0.50 ±0.2 0.48 ±0.13 0.90 ±0.11
AD/MCI 0.73 ±0.04 0.81 ±0.06 0.73 ±0.03 0.75 ±0.05 0.89 ±0.05
Recall
CN 0.24 ±0.09 0.57 ±0.1 0.17 ±0.09 0.31 ±0.15 0.72 ±0.11
AD/MCI 0.87 ±0.08 0.78 ±0.07 0.91 ±0.1 0.87 ±0.05 0.96 ±0.05
MeanF1
CN 0.29 ±0.08 0.54 ±0.09 0.24 ±0.1 0.36 ±0.13 0.79 ±0.05
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Shallow Models.  
When a particular modality is not available, we mask it as zeros when using DL. 
The intermediate features from the three modalities are passed to the classification layer. 
We test kNN, decision trees, random forests, and support vectors machines as alternatives 
for the classification layer. Internal cross-validation (CV) accuracy (Table 6.4a) using deep 
models followed by random forests as the classification layer are the best.  Deep models 
for the combination of the three modalities outperform single-modalities DL. In addition, 
during combination deep model outperforms shallow models such as feature-level and 
decision-level for both CV and external test sets (Table 6.5.).   
Combination of SNP and EHR modalities: Deep Model Outperforms Shallow Models. 
Internal CV accuracy of 0.78 ± 0 using deep models followed by random forests as 
the classification layer (Table 6,4b.) are the best. The deep models for EHR + SNP 
combinations outperform single-modalities DL. During combination,  deep model 
outperforms shallow models such as feature-level combination models for both CV and 
external test sets (Table 6.5.).  
Combination of Imaging and EHR modalities: Deep Model Outperforms Shallow 
Models. 
Internal CV accuracy of 0.79 ± 0 using deep models followed by random forests 
and SVM as the classification layers (Table 6.4c.) are the best. The deep models for EHR 
+ imaging combinations outperform single-modalities DL. In addition, during 
combination, DL model outperforms shallow models such as feature decision-level 
combination models for both CV and external test sets (Table 6.5.). Random forests as the 
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Table 6.4: Internal Cross Validation Results for Integration of Data Modalities to Predict Alzheimer’s 
Stage  a, b, c) Deep learning prediction performs better than shallow learning predictions b) Deep learning 
prediction performs better than shallow learning predictions d) Shallow learning gave a better prediction 
than deep learning due to small sample sizes. (kNN: k-Nearest Neighbors, SVM: Support Vector 
Machines, RF: Random Forests, SM: Shallow Models, and DL: Deep Learning). 
  
a: Alzheimer disease stage prediction using Imaging + EHR + SNP modalities to predict CN vs MCI vs AD.   
  
b: Alzheimer disease stage prediction using EHR + SNP modalities to predict CN vs MCI vs AD.  
  
c: Alzheimer disease stage prediction using Imaging + EHR modalities to predict CN vs MCI vs AD.  
  












CN 0.73 ± 0.13 0.67 ± 0.13 0.87 ± 0.02 0.87 ± 0.02 0.87 ± 0.03 0.88 ± 0.02
MCI 0.57 ± 0.12 0.7 ± 0.12 0.79 ± 0.03 0.79 ± 0.02 0.79 ± 0.04 0.8 ± 0.02
AD 0.61 ± 0.13 0.64 ± 0.09 0.87 ± 0.02 0.87 ± 0.02 0.87 ± 0.03 0.87 ± 0.02
Precision
CN 0.64 ±0.16 0.51 ±0.17 0.76 ±0.05 0.79 ±0.02 0.79 ±0.05 0.81 ±0.05
MCI 0.24 ±0.17 0.56 ±0.2 0.72 ±0.05 0.70 ±0.04 0.70 ±0.06 0.72 ±0.03
AD 0.62 ±0.14 1 ±0 0.87 ±0.04 0.87 ±0.04 0.87 ±0.05 0.86 ±0.04
Recall
CN 0.70 ±0.21 0.93 ±0.09 0.9 ±0.04 0.84 ±0.05 0.85 ±0.06 0.85 ±0.06
MCI 0.22 ±0.16 0.70 ±0.2 0.68 ±0.07 0.71 ±0.05 0.71 ±0.08 0.71 ±0.07
AD 0.62 ±0.24 0.27 ±0.17 0.78 ±0.06 0.8 ±0.03 0.79 ±0.04 0.81 ±0.05
MeanF1
CN 0.66 ±0.16 0.65 ±0.14 0.82 ±0.03 0.81 ±0.03 0.82 ±0.04 0.83 ±0.04
MCI 0.26 ±0.09 0.6 ±0.14 0.69 ±0.05 0.70 ±0.04 0.70 ±0.05 0.71 ±0.03






















DL + kNN DL + SVM DL + Decision Trees
DL + RF
Accuracy
CN 0.87 ± 0.03 0.77 ± 0.04 0.88 ± 0.02 0.88 ± 0.02 0.87 ± 0.03 0.88 ± 0.02
MCI 0.77 ± 0.06 0.76 ± 0.06 0.79 ± 0.03 0.79 ± 0.01 0.79 ± 0.04 0.79 ± 0.02
AD 0.82 ± 0.04 0.78 ± 0.04 0.86 ± 0.02 0.87 ± 0.01 0.87 ± 0.03 0.87 ± 0.02
Precision
CN 0.81 ±0.08 0.59 ±0.05 0.79 ±0.03 0.79 ±0.04 0.79 ±0.05 0.79 ±0.04
MCI 0.72 ±0.07 0.74 ±0.08 0.72 ±0.06 0.71 ±0.03 0.7 ±0.06 0.71 ±0.04
AD 0.72 ±0.09 1 ±0 0.85 ±0.05 0.87 ±0.03 0.87 ±0.05 0.85 ±0.03
Recall
CN 0.78 ±0.06 1 ±0 0.87 ±0.05 0.88 ±0.04 0.85 ±0.07 0.87 ±0.03
MCI 0.75 ±0.1 0.74 ±0.06 0.68 ±0.08 0.7 ±0.06 0.71 ±0.07 0.69 ±0.06
AD 0.7 ±0.1 0.31 ±0.12 0.8 ±0.07 0.79 ±0.04 0.79 ±0.05 0.8 ±0.05
MeanF1
CN 0.8 ±0.06 0.74 ±0.04 0.83 ±0.03 0.83 ±0.02 0.82 ±0.05 0.83 ±0.03
MCI 0.73 ±0.07 0.74 ±0.06 0.69 ±0.04 0.7 ±0.03 0.7 ±0.05 0.7 ±0.04






















DL + kNN DL + SVM




CN 0.85 ± 0.05 0.58 ± 0.09 0.86 ± 0.03 0.88 ± 0.03 0.88 ± 0.03 0.88 ± 0.04
MCI 0.78 ± 0.05 0.38 ± 0.1 0.8 ± 0.03 0.8 ± 0.03 0.79 ± 0.04 0.8 ± 0.03
AD 0.83 ± 0.08 0.38 ± 0.08 0.87 ± 0.03 0.88 ± 0.02 0.87 ± 0.03 0.87 ± 0.03
Precision
CN 0.7 ±0.06 0.52 ±0.08 0.75 ±0.04 0.8 ±0.06 0.8 ±0.06 0.79 ±0.04
MCI 0.44 ±0.38 0.16 ±0.12 0.74 ±0.05 0.71 ±0.05 0.71 ±0.06 0.71 ±0.05
AD 0.82 ±0.08 0 ±0 0.84 ±0.05 0.87 ±0.04 0.86 ±0.06 0.87 ±0.04
Recall
CN 0.87 ±0.07 1 ±0 0.85 ±0.04 0.86 ±0.04 0.85 ±0.07 0.87 ±0.08
MCI 0.13 ±0.11 0.38 ±0.19 0.68 ±0.04 0.71 ±0.08 0.71 ±0.08 0.7 ±0.05
AD 0.92 ±0.07 0 ±0 0.81 ±0.05 0.81 ±0.05 0.8 ±0.05 0.8 ±0.04
MeanF1
CN 0.77 ±0.06 0.68 ±0.07 0.8 ±0.04 0.82 ±0.04 0.82 ±0.05 0.83 ±0.06
MCI 0.27 ±0.1 0.22 ±0.14 0.71 ±0.04 0.71 ±0.05 0.71 ±0.06 0.71 ±0.04






















DL + kNN DL + SVM






0.75 ± 0.11 0.51 ± 0.12 0.74 ± 0.08 0.72 ± 0.06 0.73 ± 0.08 0.74 ± 0.09
Precision
CN 0.67 ±0.25 0.37 ±0.12 0.74 ±0.08 0.72 ±0.06 0.73 ±0.08 0.74 ±0.09
AD/MCI 0.78 ±0.12 0.9 ±0.13 0.69 ±0.4 0.55 ±0.11 0.54 ±0.12 0.61 ±0.2
Recall
CN 0.39 ±0.15 0.93 ±0.09 0.74 ±0.07 0.79 ±0.06 0.81 ±0.05 0.8 ±0.06
AD/MCI 0.91 ±0.07 0.34 ±0.15 0.22 ±0.24 0.49 ±0.18 0.54 ±0.16 0.5 ±0.16
MeanF1
CN 0.48 ±0.15 0.51 ±0.12 0.97 ±0.05 0.82 ±0.09 0.8 ±0.09 0.84 ±0.13
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classification layer give the best performance on the external set.  
Combination of Imaging and SNP modalities: Shallow Model Outperforms Deep Models. 
We perform two-class classification using a combination of SNP and imaging 
intermediate features (CN vs AD/MCI). Internal CV accuracy of 0.75 ± 0.11, using feature-
level combination models (Table 6.4d) is the best. However, the results on the external data 
are poor. This can be attributed to the small overlap of 220 samples between the two 
Table 6.5: Features extraction from deep models and comparison of internal validation 
results with external test result. Autoencoder models are preferred for EHR and SNP 
data and CNN for imaging data. For multi-modality models, the three modality models 
and two modality models (EHR + SNP, EHR + imaging gave the best prediction 
performance). For the multi-modality models, 3 or 4 combinations deep models 
outperformed shallow models. 
 Models 







Regularization coefficients (.03,.03) 
Dropouts (0.6,0.6,0.6) 
Layer sizes (200,100,75) 
Accuracy: 0.78 ± 0.03 
Precision: 0.78 ± 0.04 
Recall: 0.78 ± 0.05 
F1 Scores: 0.77 ± 0.04 
Accuracy: 0.76 
Precision: 0.76 
Recall: 0.77  




Highest on validation (Dropout- .5, 
Batch size 5 , Layer size(20), # areas 
= 5) 
Highest on external test (SVM kernel 
= linear) 
Accuracy: 0.86 ± 0.04 
Precision: 0.86 ± 0.04 
Recall: 0.87 ± 0.04 
F1 Scores: 0.86 ± 0.04 
Accuracy: 0.84  
Precision: 0.83  
Recall: 0.83  





Regularization coefficients (.03,.03), 
Dropouts(0.6,0.6,0.6) 
Layer sizes(200,100,50) 
Accuracy: 0.89 ± 0.03 
Precision: 0.9 ± 0.04 
Recall: 0.84 ± 0.03 




F1 Scores: 0.53 




Regularization coefficients (.03,.03) 
Dropouts(0.6,0.6,0.6) 
Layer sizes(200,100,50) 
Random Forest Trees = 31 
Accuracy: 0.79 ± 0 
Precision: 0.79 ± 0.07 
Recall: 0.79 ± 0.07 




F1 Scores: 0.78 




Regularization coefficients (.03,.03) 
Dropouts(0.6,0.6,0.6) 
Layer sizes(200,100,50) 
Random Forest Trees = 31 
Accuracy: 0.78 ± 0 
Precision: 0.79 ± 0.07 
Recall: 0.79 ± 0.09 




F1 Scores: 0.78 




Regularization coefficients (.03,.03) 
Dropouts(0.6,0.6,0.6) 
Layer sizes(200,100,50) 
Random Forest Trees = 31; 
Accuracy: 0.79 ± 0 
Precision: 0.79 ± 0.08 
Recall: 0.79 ± 0.08 




F1 Scores: 0.77 




Random Forest Trees = 20;  
Accuracy: 0.75 ± 0.11 
Precision: 0.72 ± 0.16 
Recall: 0.65 ± 0.09 









6.3.5 Discussion for Novel DL and Multi-Modality Data Analysis 
Our results indicate that the deep models outperform traditional shallow models for 
single-modalities. This is because shallow models require expert crafted features that are 
mutually uncorrelated, while deep models can find the optimal set of features during 
training. In addition, deep models such as autoencoders and CNNs perform unsupervised 
feature generation, which allows us to combine the models with more sophisticated 
decision layer and facilitates the modeling of complex decision boundaries for multiclass 
class problems [314]. Due to this property, deep models are particularly effective for the 
identification of MCI, which has been a clinical challenge in Alzheimer’s research due to 
small differences between the three groups. Shallow models (except random forests ) also 
do not tolerate noisy and missing data or missing modalities well. As a result, in noisy data, 
DL gives the best performance for single-modalities.  
 Integration of multiple modalities improves the prediction accuracy (three of four 
scenarios). The deep models for integration also show improved performance over 
traditional feature-level and decision-level integrations. The superior performance of the 
DL is due to its ability to extract relationships amongst features from different modalities. 
When the dataset is very small (combination of Imaging and SNP), deep models do not 
perform well. This is due to the fact that deep models need larger datasets for training 
[315]. Overall our investigations show that 
• for single-modality data (clinical, and imaging), the performance of DL 
models are always better than those of shallow models; and 
• when using DL models, predictions by multi-modality data is better than 
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that of single-modality data, and the three best fusion set ups are: EHR + SNP, EHR + 
Imaging + SNP, and EHR + Imaging. 
6.3.6 Interpretation of Deep-Models: 
Model interpretation is a major challenge for deep learning, which is often 
considered as a barrier for real world applications of deep models in the biomedical 
domain. Research has shown that weights of deep models affect the results through several 
layers and combinations, hence do not yield clinically meaningful interpretations [235].  
As mentioned above, interpretability of deep-learning models is challenging. 
However, the Interpretability of deep-learning models constitutes a major challenge. In this 
work, we interpret the models by masking one feature at a time, the features which gave 
highest drop in accuracy was picked as the top features. For each repeat, we gave the top 
features, the  highest score. We rank the feature with the highest average score the top 
 
Figure 6.4: Model interpretation pipeline. The features for the deep models are 
masked one at a time and the effect on the classification is observed. The feature 
which gives the highest drop in accuracy is ranked the highest. Once we ranked the 
features, we checked if the intermediate picked associations different from raw data 
using cluster analysis. 
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feature. For interpretation, we picked the model with the performance in each of the four 
integrations and for each individual model (Figure 6.4).  
The top EHR features (Table 6.6) include memory tests, imaging summary scores, 
and brain volumes. Changes to memory and brain volumes have been reported as AD 
biomarkers. Imaging markers such as involvement of limbic and cortical regions [288], 














































































































































































































































































































































































































































































and changes in hippocampus volume and structure [289, 316] are known biomarkers in 
positron emission tomography (PET) and magnetic resonance imaging (MRI) studies.  SNP 
features picked chromosome 10, and 4.  
SNP + Imaging + EHR  and SNP + EHR pick more EHR features (memory tests, 
metabolic markers and brain volume) which are known AD related features. EHR + 
Imaging pick EHR features including brain volumes, clinical dementia ratings, and 
metabolite markers. Imaging + SNP pick brain areas such as the hippocampus, and 
amygdala higher than SNP features. 
In addition, we also clustered the intermediate features from EHR and SNP data 
were first clustered using kmeans to show associations in intermediate features. We tested 
  
a     b 
Figure 6.5: Cluster analysis results: EHR Data. a) gives the intermediate features 
plotted against the top ranked features which discriminated the two clusters using 
relieFF. b) a) gives the original data plotted against the top ranked features which 
discriminated the two clusters using relieFF 
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cluster number of 2-20 to pick the optimum cluster number using clustering scores. The 
cluster number was evaluated using the mode of cluster number generated using Calinski 
Harabasz [267], Davies-Bouldin [268], silhouette [269] and gap scores [270]. Then we 
checked the features which discriminated the clusters using relieFF feature selection 
algorithm. The top features which consistently discriminated the clusters across multiple 
folds and repeats in the training and test sets for both EHR and SNP data are reported. On 
plotting the clusters for intermediate and raw features, we found that the intermediate 
features generated better separation as compared to the original features. This indicates 
subtle relationships in intermediate features, which were picked by deep-models (Figures 
6.5, 6.6.).  
The top EHR features which discriminated the two clusters include imaging score 
  
a      b 
Figure 6.6: Cluster analysis results: SNP Data. a) gives the intermediate features 
plotted against the top ranked features which discriminated the two clusters using 
relieFF. b) a) gives the original data plotted against the top ranked features which 
discriminated the two clusters using relieFF 
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summaries and memory tests. More specifically, the features include limbic medial-
temporal GM, unit recall test, left frontal operculum, left superior temporal gyrus, 
executive function summary, story recall memory test, clinical dementia rating, left 
posterior orbital gyrus, left superior frontal gyrus, and left superior occipital gyrus. The top 
SNP features which discriminated the two clusters include chromosome 19, 22, and 10. All 
these chromosomes are well-known genes which are associated with Alzheimer’s disease. 
The top SNP locations involved include 45396144, 46619419, 45387596, 45410444, 
68854980, 68854824, 45396219, 68838270, 50862870, 68821956.  
6.4. Conclusion and Key Innovations 
Less than 50% of the people with Alzheimer’s are diagnosed accurately on the basis 
of their clinical symptoms. Current biomarkers for AD are based on a single data modality 
and the prediction accuracy also remains low for patient stage classification. In this study, 
we integrate multiple datasets using deep learning methods (stacked de-noising auto-
encoders, and 3D- convolutional neural network), to achieve synergistic boosts in 
accuracy. We demonstrate a statistically significant improvement over baseline models 
including, support vector machines, decision trees, and k nearest neighbors on ADNI 
dataset. Despite the improved performance, our study suffers from short-comings such as 
limited dataset sizes . In the future, we will test our models on a larger and richer dataset.  
 To summarize, the key innovations of this chapter include: 
• Deep-models outperform shallow models for single-modality Alzheimer’s 
stage prediction. 




• Novel perturbation and clustering based feature extraction assisting DL 
model interpretations are capable of AD stage prediction. 
• Application of 3D convolutional neural network architecture for MRI image 
data analysis in Alzheimer’s disease.  
 Despite the improved performance, our study suffers from short-comings 






 CONCLUSION & FUTURE WORK 
The concrete goals of this dissertation were to develop decision support tools for 
the prediction of adverse outcomes using electronic health records. The specific technical 
achievements of this dissertation corresponding to the three research objectives are (Figure 
7.1):  
1. Development and validation of quality control measures and novel imputation 
techniques for multiple types of missing data in EHR. 
2. Construction of predictive models and visualizations using temporal predictive 
models applicable to adverse event detection such as ICU mortality, ICU 
readmission, sepsis and respiratory distress syndrome. 
 
Figure 7.1: Summary of dissertation topic 
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3. Development and validation of integrated heterogenous temporal sequences and 
genetic data using deep learning for predicting adverse condition such as long ICU 
stay and Alzheimer’s disease stages. 
7.1.  Concrete Innovation Deliverables 
The key innovations of this dissertation, as noted at the closing of each chapter, are 
summarized below:  
• (Chapter 2) Categorization of missing data in EHR into multiple types. 
• (Chapter 2) Development of novel missing data types for multiple types of missing 
data. 
• (Chapter 2) Evaluation of missing data imputation using adult and pediatric datasets. 
• (Chapter 3) Development of time series data analysis models for ICU data without 
explicit independence assumptions. 
• (Chapter 3) Analysis of adults and pediatric models for ICU mortality, 30 day ICU 
readmission, sepsis and RDS. 
• (Chapter 3) First study to combine CRF with survival curves to show individual 
patient risk profiles 
• (Chapter 4) Combination of static and temporal data for mortality and 30 day ICU 
readmission. 
• (Chapter 4) Integration demonstrates synergistic improvement for integration models 
over individual modalities. 
• (Chapter 5) Development of a framework for combining data from multiple temporal 
resolutions using deep models. 
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• (Chapter 5) Evaluation of integration models to demonstrate ICU length of stay 
prediction on pediatric ICU patient data. 
• (Chapter 5) Development of a clustering based analysis for data interpretation. 
• (Chapter 6) Development of a framework for combining data from multiple sources 
using deep models. 
• (Chapter 6) Evaluation using Alzheimer’s disease dataset to demonstrate that deep 
models outperformed shallow models within each modality and combination models 
outperformed individual models. 
• (Chapter 6) Development of a clustering based analysis for data interpretation. 
7.2. Concrete Publication Deliverables 
The section provides a comprehensive list of publications completed during my 
years as a Ph.D. student.  
Published or Accepted for Publication 
Journals 
• C. Cheng, N. Chanani, J. Venugopalan, K. Maher, and D. Wang, "icuARM–An 
ICU Clinical Decision Support System Using Association Rule Mining," 2013.  
• P. Wu, C. Cheng, C Kaddi, J Venugopalan, R Hoffman, and MD Wang, ” -Omic 
and Electronic Health Records, Big Data Analytics for Precision Medicine,” in 
Transactions in Biomedical Engineering 2016.  
• J Venugopalan, N. Chanani, K. Maher, and MD. Wang, ” Novel Data Imputation 
for Multiple Types of Missing Data in Intensive Care Units,” in Journal of 
Biomedical and Health Informatics, 2017.  
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• J Venugopalan, Y Sha, T Buchman, MD Wang. “Data quality control in critical 
care.” in SCCM Medicine (Under Review).  
Conferences 
• J. Venugopalan, C. Chihwen, and M. D. Wang, "MotionTalk: Personalized home 
rehabilitation system for assisting patients with impaired mobility," in ACM 
Conference on Bioinformatics, Computational Biology and Health Informatics 
(ACM-BCB) 2014 Annual International Conference of ACM 2014. 
• J. Venugopalan, C. Chihwen, T. H. Stokes, and M. D. Wang, " Kinect-based 
Rehabilitation System for Patients with Traumatic Brain Injury," in Engineering in 
Medicine and Biology Society (EMBC), 2013 Annual International Conference of 
the IEEE, 2013.  
• J. Venugopalan, C. Brown, C. Chihwen, T. H. Stokes, and M. D. Wang, "Activity 
and school attendance monitoring system for adolescents with Sickle cell disease," 
in Engineering in Medicine and Biology Society (EMBC), 2012 Annual 
International Conference of the IEEE, 2012, pp. 2456-2459.  
• J. Ren, J. Venugopalan, J. Xu, B. Kairdolf, and M. D. Wang, " Multi-Channel LED 
Light Source for Fluorescent Agent Aided Minimally Invasive Surgery", in 
Engineering in Medicine and Biology Society (EMBC), 2014 Annual International 
Conference of the IEEE, 2014. 
• R. Durfee, J. Venugopalan, J. Ren , and M. D. Wang, " Multi-Channel LED Light 
Source for Fluorescent Agent Aided Minimally Invasive Surgery", in Point of Care 
(POC), 2014 Annual International Conference of the IEEE, 2014.  
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• C. Cheng, R. C. Brown, L. L. Cohen, J. Venugopalan, T. H. Stokes, and M. D. 
Wang, "iACT-An interactive mHealth monitoring system to enhance psychotherapy 
for adolescents with sickle cell disease," in Engineering in Medicine and Biology 
Society (EMBC), 2013 35th Annual International Conference of the IEEE, 2013, 
pp. 2279-2282. 
• TH Stokes, J Venugopalan, EN Hubbard, and MD Wang. “A pilot biomedical 
engineering course in rapid prototyping for mobile health. “ Conf Proc IEEE Eng 
Med Biol Soc, EMBC. 2013 Jul 3; 2515-2518.  
• I Raharjo, J Venugopalan, T Burns, MD Wang. “Development of user-friendly and 
interactive data collection system for cerebral palsy.” Biomedical and Health 
Informatics (BHI), 2016. 
• Y. Sha, J Venugopalan, N. Chanani, K. Maher, and M.D. Wang, ” A Novel 
Temporal Similarity Measure for Patients Based on Irregularly Measured Data in 
Electronic Health Records,” in ACM Conference on Bioinformatics, 
Computational Biology and Health Informatics (ACM-BCB) 2016 Annual 
International Conference of ACM 2016.  
• J Venugopalan, M LaPlaca, and MD Wang, " Mining standardized neurological 
signs and symptoms data for concussion identification." in Biomedical and Health 
Informatics (BHI), 2017 IEEE-EMBS International Conference on, 2017.  
• J Venugopalan, N Chanani, KO Maher, and MD. Wang. "Combination of static 
and temporal data analysis to predict mortality and readmission in intensive care 




• J. Venugopalan, R. Hoffman, C. Cheng, M. D. Wang, “Time-series data analysis to 
predict mortality and cardiac arrest in pediatric populations,” in 2014 Pediatric 
Healthcare Innovation Conference 
• J. Venugopalan, C. Chihwen, T. H. Stokes, and M. D. Wang, "Cloud –Based 
Integrative Pain Management System"—Wireless Health 2013 
• J. Venugopalan, C. Chihwen, T. H. Stokes, and M. D. Wang, " Kinect-based 
Rehabilitation System for Patients with Traumatic Brain Injury,"- BMES 2013 
• Venugopalan, C. Brown, C. Chihwen, T. H. Stokes, and M. D. Wang, "Activity and 
school attendance monitoring system for adolescents with Sickle cell disease," in 
BMES 2012 
• Venugopalan J, Chanani N, Maher KO and Wang MD. "Data quality control for 
the improved prediction of readmission in intensive care unit" in Annual Critical 
Care Congress,SCCM, 2015 
Manuscripts under Review 
• J Venugopalan, N Chanani, KO Maher, and MD. Wang. “Time-series analysis of 
intensive care data to predict mortality and readmission.” in Journal of Biomedical 
Informatics [ 
• J Venugopalan, H Hassanzadeh, L Tong, and MD Wang. “Multimodal analysis 
using deep-learning for Alzheimer's disease detection”, in Journal of American 
Medical Informatics Association. 
• J Venugopalan, N Chanani, KO Maher, and MD Wang. “Integration of static and 
temporal data analysis using deep learning to predict length of stay in the intensive 
care unit ” 
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7.3. Directions for Future Research and Concluding Remarks 
The models and tools developed in this dissertation are complete and fully 
functional. However, it is essential to identify potential directions for future research to 
help improve the current work and applications. The specific potential research extensions 
are discussed at the end of each chapter. In addition to those, the high level extensions of 
this thesis work are discussed here. The opportunities are can be application novelties and 
data-mining opportunities. 
7.3.1 Application Opportunities 
In this chapters, I have showcased the application of data imputation, time-series 
analysis and data integration to datasets of varying sizes from a few hundred samples to a 
thousands of data samples. The ICU datasets included static data, temporal lab and vital 
signs data. We showcased prediction of ICU mortality, readmission, sepsis, RDS and 
length of stay for adult, pediatric and neonatal population. The techniques and tools 
developed in this dissertation can be readily deployed to higher frequency data such as 
waveform data. It can also be used in other research domains such as public health analysis, 
molecular data analysis, and insurance data analysis.  
In addition, to this data sizes is a major challenge in healthcare research. Most data 
mining models, especially deep-learning models benefit greatly from larger datasets. Since 
data collection is expensive, creation of synthetic data using available patient data for 
training of the models has the potential for improving the prediction of the decision support 
systems. Generative models such as hidden markov models[317], generative adversarial 
networks[318] and generative long-short-term memory networks[319] are some candidate 
techniques which can be used for this analysis. 
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7.3.2 Data Mining Opportunities 
Data Quality 
Meaningful” use of EHR data and evidence-based medicine are concepts which 
have a great potential in the areas of comparative effectiveness research, predictive 
analytics, improved clinical outcomes research, personalized medicine, and precision 
medicine. However, clinically actionable results can be obtained only when the data is of 
sufficient quality to promote the decision support systems. In order to accelerate the quality 
of data in EHR and critical care systems, more research is needed in the areas of i) data 
normalization framework to integrate data from heterogeneous sources and multiple 
institutions (e.g. data ontology studies, HL7, FHIR[320], SHARPn [321], eMERGE [322], 
MIMIC [149]); ii) data quality indices development and evaluation ( e.g. IBM Watson, 
SHARPn [321]; iii) data cleaning algorithms (e.g. error and artefact removal, data 
imputation); iv) natural language processing for clinical notes; and v) development of 
robust phenotyping algorithms (e.g. dealing with irregularly sampled data).  
In addition, to effectively use EHR data, the different quality issues need to be 
addressed at different times in the healthcare process by the different stakeholders 
including investigators (e.g. researchers, statisticians, clinical PIs), users (e.g. physicians, 
business data analysts) , evaluators and policy makers.  
Investigators 
 Quality control practices during data collection, aggregation, design of study 
experiments, and data analysis are very important for successful adoption of the results into 
clinical practice. Despite research, there is no clear consensus on the handling of the issues 
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in ICU data. Research is needed in the areas of data normalization from heterogeneous 
sources and multiple institutions; data quality indices and evaluation ( e.g. IBM Watson, 
SHARPn [321]); data cleaning algorithms (e.g. error and artefact removal, data 
imputation); natural language processing; and the development of robust phenotyping 
algorithms (e.g. dealing with irregularly sampled data). 
Users 
Data quality at the time of data entry and interpretation of the studies are essential for 
improved quality of care. Several recommender systems for data entry and rules to detect 
outliers have been proposed and have been shown to have an impact on data quality. Data 
sharing, education, and involvement in the development of decision support have been 
proposed for improving data quality [323] and quality of care.  
Evaluators and Policy Makers 
The US Food and Drug Administration (FDA) is taking an active interest in clinical 
DSS, and mobile software [324]. The major concerns are addressed by FDA by creating 
specific regulations for the category wise division of adverse effects: (1) the acquisition of 
the wrong patient record or incorporation of misinformation, (2) the omission or 
obliteration of patient data, (3) falsified data processing, and (4) the incompatibility 
between multi-vendor application and systems [325, 326]. FDA is also monitoring decision 




Temporal Data Mining 
 In this dissertation, we showcased the development of temporal data mining, and 
combination of heterogenous temporal resolution data using machine learning and deep-
learning techniques. An extension of the current work would be to include irregularly 
sampled data for analysis. The few studies which deal with irregular sampling, primarily 
use imputation techniques and robust parameter extraction [327]. Some work on the 
visualization of irregularly sampled data to assist physicians to make a decision has also 
been done  [110]. Most of this work is however concentrated on the waveform analysis. 
Research on the use of integrated clinical data with irregular sampling is still a more open 
research area. 
Integration Research 
In this dissertation, I showcase the integration of temporal and multiple different 
datatypes using deep-learning techniques. Due to limitation of dataset sizes, we chose 
relatively simple deep-learning models such as autoencoders, and LSTM networks. With 
the availability of large datasets, using techniques like transfer learning [328, 329] on large 
models developed using open source models developed for social network and imaging 
data are potential directions. 
7.3.3 Concluding Remarks 
In this dissertation, I have developed a suite of quality control, data mining and 
deep learning tools to address key challenges in clinical decision support research. It 
includes models for data imputation, time-series analysis and data integration that have 
been successfully applied to investigate adverse ICU outcomes. In the preceding sections, 
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